US20080146900A1 - Method and apparatus for providing power management in data communication systems - Google Patents
Method and apparatus for providing power management in data communication systems Download PDFInfo
- Publication number
- US20080146900A1 US20080146900A1 US12/040,586 US4058608A US2008146900A1 US 20080146900 A1 US20080146900 A1 US 20080146900A1 US 4058608 A US4058608 A US 4058608A US 2008146900 A1 US2008146900 A1 US 2008146900A1
- Authority
- US
- United States
- Prior art keywords
- meter
- display unit
- housing
- blood glucose
- light source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- 238000004891 communication Methods 0.000 title description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 205
- 239000008103 glucose Substances 0.000 claims abstract description 205
- 238000012360 testing method Methods 0.000 claims abstract description 134
- 239000008280 blood Substances 0.000 claims abstract description 129
- 210000004369 blood Anatomy 0.000 claims abstract description 129
- 238000012905 input function Methods 0.000 claims abstract description 10
- 230000006870 function Effects 0.000 claims description 23
- 238000003780 insertion Methods 0.000 claims description 14
- 230000037431 insertion Effects 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 9
- 239000004973 liquid crystal related substance Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 4
- 238000005286 illumination Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 description 26
- 238000005259 measurement Methods 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 238000012552 review Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 239000012491 analyte Substances 0.000 description 3
- 239000003086 colorant Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
- G01D11/00—Component parts of measuring arrangements not specially adapted for a specific variable
- G01D11/24—Housings ; Casings for instruments
- G01D11/245—Housings for sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
- G01D11/00—Component parts of measuring arrangements not specially adapted for a specific variable
- G01D11/24—Housings ; Casings for instruments
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/4875—Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
- G01N33/48778—Containers specially adapted therefor, e.g. for dry storage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0209—Operational features of power management adapted for power saving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Definitions
- the present invention relates to data monitoring systems. More specifically, the present invention relates to portable analyte monitoring systems. More specifically, the present invention relates to a compact, blood glucose meter for use in a glucose monitoring system to self-monitor glucose level in whole blood, as an aid to disease management, and also by healthcare professionals as an aid to monitor the effectiveness of diabetes treatment.
- a blood glucose meter which is designed to be substantially more compact than presently available commercial blood glucose meters, which configuration that is much more amenable to usage and portage by younger diabetic patients such as children.
- the blood glucose meter is configured to include a LCD backlight and a flashlight features which will assist the patient in reading the metered glucose level in low-light testing areas such as in theaters, low ambient light restaurants, areas, outdoors during non-daylight times and so on, as well as a light source to guide the insertion and removal of the test strip, which may include the usage of a light emitting diode.
- the light source e.g., the LED
- the battery life of the glucose meter device may be prolonged since the pulsed LED light source requires significantly less power (and thus draining the battery at a much slower rate) than when the LED light source is maintained at the on position.
- the central processing unit of the glucose meter device may be configured to control the switching on and off of the light source as well as the level of light intensity by, for example, adjusting the duty cycle and the period during which the light source is configured to be turned on.
- the blood glucose meter may include a numerically displayed clock with a date display which may be visible when the meter is not in use.
- the clock feature in yet a further embodiment of the present invention may include an alarm which would allow the users to set alarm reminder for performing blood glucose level testing, where the alarm feature may include one or a combination of an auditory alarm, a visual alarm alert, and a vibration alert mode.
- a blood glucose meter in accordance with one embodiment of the present invention includes a compact housing for a blood glucose meter, a display unit disposed on the housing, the display unit configured to display information related to the blood glucose meter, an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter, and a power source provided within the housing for providing power to the blood glucose meter.
- the display unit may include one of a liquid crystal display (LCD), a touch sensitive screen, and a plasma display unit.
- LCD liquid crystal display
- touch sensitive screen a touch sensitive screen
- plasma display unit a plasma display unit
- the display unit may also include a light source to illuminate the display unit, where the light source may be configured to provide a backlight function and a flashlight function of the display unit.
- the light source in one embodiment may be configured to be pulsed at a frequency greater than 60-100 Hertz. Moreover, the light source may further configured to have a peak wavelength of approximately 570 nanometers.
- the light source may include a light emitting diode (LED), and more specifically, a yellow-green LED.
- LED light emitting diode
- the housing may include a port integrated on the housing configured to receive a blood glucose test strip.
- the port may include a light source that may be configured to substantially illuminate the port to assist in the insertion and/or removal of the blood glucose test strip.
- the display unit may be configured to illuminate upon detection of a blood glucose test strip insertion into the port. Further, the display unit may be configured to remain illuminated until the test strip is removed from the port.
- the input unit in one embodiment may include an on/off switch.
- a blood glucose meter in accordance with another embodiment includes a compact housing for a blood glucose meter, a display unit disposed on the housing, the display unit including a display light source to illuminate the display unit, an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter, and a power source provided within the housing for providing power to the blood glucose meter, where the housing includes a port integrated on said housing configured to receive a blood glucose test strip.
- the port in one embodiment may include a port light source, the port light source configured to substantially illuminate the port to assist in the insertion and/or removal of the blood glucose test strip.
- the port light source may be integrated with the display light source.
- a method of measuring blood glucose level in accordance with yet another embodiment of the present invention includes the steps of providing a compact housing, disposing a display unit on the housing, the display unit including a display light source to illuminate the display unit, disposing an input unit on the housing, the input unit configured to provide input functions for the blood glucose meter, providing a power source within the housing for providing power to the blood glucose meter, where the housing includes a port integrated on said housing configured to receive a blood glucose test strip.
- FIG. 1 is a block diagram illustrating an overall glucose monitoring system in accordance with one embodiment of the present invention
- FIG. 2 is a block diagram illustrating a glucose meter device shown in FIG. 1 in accordance with one embodiment of the present invention
- FIG. 3 illustrates the glucose meter device of FIG. 2 in accordance with one embodiment of the present invention
- FIGS. 4A and 4B illustrate the display screen of the glucose meter device in accordance with one embodiment of the present invention
- FIG. 5 is a flowchart illustrating the procedure for performing a blood glucose test using the glucose meter device in accordance with one embodiment of the present invention.
- FIG. 6 illustrates the output LED power level as a function of the power state in accordance with one embodiment of the present invention.
- FIG. 1 is a block diagram illustrating an overall glucose monitoring system in accordance with one embodiment of the present invention.
- the glucose monitoring system 100 in accordance with one embodiment includes a glucose meter device 103 configured to receive a test strip 102 which is used to collect the blood sample for determining the blood glucose level of the user 101 .
- the lancing device 104 is used to draw the blood sample from the user 101 to be collected onto the test strip 102 .
- the lancing device 104 may be used on the user's fingers, forearm, upper arm, hand, thigh or calf, for example.
- the glucose meter device 103 and the system 100 is configured such that a very small blood sample size such as, for example, approximately 0.3 microliter of sample blood, is necessary to determine a corresponding blood glucose level.
- the glucose meter device 103 may be operatively coupled to an external computer 105 which may include, in one embodiment, a server terminal connected to a data network, a stand along desktop or laptop computer for use by the user's physician or care provider (or the user herself), a personal digital assistant (PDA) which is operatively configured to store and/or further, to communicate with a data network to transmit and receive patient data related to the glucose level detected from the collected blood sample, for further diagnosis, analysis and the like.
- PDA personal digital assistant
- the user 101 may provide the configuration parameters as well as calibration code to the glucose meter device 103 , while the glucose meter device 103 may be configured to output signal prompts to the user 101 such as to indicate a sample fill signal and a sample result signal, and further, to output display the resulting measured blood glucose level from the sampled blood from the user 101 .
- the test strip 102 is provided in contact thereto (i.e., to the sample blood) while the test strip 102 is operatively coupled to the glucose meter device 103 .
- the glucose meter device 103 may in one embodiment be configured to alert the user that the amount of blood sample on the test strip 102 is sufficient to determine the corresponding blood glucose level.
- the glucose meter device 103 may be configured to make clinical measurements of glucose in whole blood in the range for approximately 20 to 500 mg/dL. Furthermore, as discussed in further detail below, the glucose meter device 103 may be configured to include a display unit which is configured to operate as a user interface to visually interact with the user 101 to prompt for data input, or alternatively, to provide information to the user 101 corresponding to the user's operation of one or more functions of the glucose meter device 103 . In one embodiment, the display unit of the glucose meter device 103 may include a LCD display screen which may further be configured, in an alternate embodiment to include a touch-sensitive pad so as to allow the user 101 to input data therethrough.
- the display unit of the glucose meter device 103 may be configured to include a backlight feature which would permit the user 101 to operate the glucose meter device 103 in a dark ambient setting such as in a theater, outdoor at night, and the like.
- FIG. 2 is a block diagram illustrating a glucose meter device shown in FIG. 1 in accordance with one embodiment of the present invention.
- the glucose meter device 103 in accordance with one embodiment of the present invention includes a central processing unit 206 operatively coupled to a digital data processing unit 204 .
- the central processing unit 206 is further operatively coupled to a storage unit 207 which, in one embodiment, may include one or more of a data storage unit, a random access memory unit and a read-only memory unit.
- the digital data processing unit 204 is further operatively coupled to an input/output (I/O) interface unit 205 which, in one embodiment, is configured to interface with the external computer 105 ( FIG. 1 ).
- I/O input/output
- an analog data processing unit 201 which is configured to detect and process analog signals and which is further operatively coupled to the digital data processing unit 204 for digital data processing of the detected and processed analog signals received from the analog data processing unit 201 in one embodiment of the present invention.
- the analog data processing unit 201 of the glucose meter device 103 is further configured to operatively couple to a test strip connector unit 202 which is configured to engage with a test strip 102 ( FIG. 1 ) when inserted into the glucose meter device 103 .
- the analog data processing unit 201 as mentioned above is configured to detect the signal level from the collected blood sample received from the test strip 102 ( FIG. 1 ) via the test strip connector unit 202 , and to transmit that detected and analog processed data to the digital data processing unit 204 for further data processing.
- the user interface unit 203 is operatively coupled to the user 101 ( FIG. 1 ) to receive input data or instructions therefrom, or alternatively, to output the processed and/or generated information to the user 101 .
- the user interface unit 203 may include a display unit, an input device such as an input keypad, or any other equivalent device which may provide substantially the same functionality as the input device such as an input keypad.
- the display unit of the user interface unit 203 may include an LCD display unit which is also capable of providing backlighting so as to permit the user to view the displayed information on the backlit display unit of the user interface unit 203 in dark ambient settings.
- the user interface unit 203 may also include a flashlight feature which, upon activation by the user, is configured to emit a consistent light beam to assist the user in the operation of the glucose meter device 103 and/or the lancing device 104 in dark surroundings.
- the flashlight feature may also be configured to include a timer function such that the flashlight is configured, in one embodiment, to automatically turn off after a predetermined period of time has elapsed. In this manner, the power source for the glucose meter device 103 ( FIG. 1 ) may be conserved in the cases where the user 101 leaves the flashlight feature on the glucose meter device 103 on.
- the user interface unit 203 in accordance with a further embodiment of the present invention may include a speaker unit configured to output audio signals. More specifically, in one aspect of the present invention, the user 101 may be alerted or reminded of one or more time specific events or reminder such as the next time the user 101 needs to take a blood glucose level measurement. Rather than relying solely upon the user's memory, the glucose meter device 103 may be configured with an alarm feature operatively engaged with a timer function such that, in addition to displaying the current time information on the display unit, the glucose meter device 103 may be configured to generate and output an audible sound for each specific event or reminder which the user 101 has pre-programmed into the glucose meter device 103 .
- the audible alarm output (or a series or audible tones as may be selected by the user) may be simultaneously generated with the backlight feature of the glucose meter device 103 such that for each of use, the user is able to view information displayed on the display unit of the user interface unit 203 substantially immediately without the need to perform extra steps such as turning on the backlight function of the glucose meter device 103 .
- the meter allows the user to set up to four separate alarms to go off every 24 hours at a particular time to remind the user to test her blood glucose level.
- the volume of each alarm may be set independently.
- the central processing unit 206 is configured to perform a plurality of functions to maintain, calibrate and operate the glucose meter device 103 . More specifically, upon power up of the glucose meter device 103 when the power source such as the batteries, are placed in the respective section of the device housing, under the control of the central processing unit 206 , the glucose meter device 103 is configured to perform a power on/reset sequence to initialize the various aforementioned components of the glucose meter device 103 to the necessary configuration settings. Upon successful completion of the power on/reset sequence, the central processing unit 206 is then configured to enter the glucose meter device 103 into a default operation mode (for example, the clock mode) as discussed in further detail below.
- a default operation mode for example, the clock mode
- the central processing unit 206 is configured to access the storage unit 207 to retrieve the corresponding power on/reset sequence instruction set from the storage unit 207 (for example, in the ROM portion and/or the RAM portion thereof). Moreover, in one embodiment, the central processing unit 206 is configured to perform and complete the aforementioned power on/reset sequence within approximately 500 mseconds.
- the central processing unit 206 of the glucose meter device 103 may be configured for operating the meter device 103 in one of the following modes of operation—the clock mode (the default mode discussed above), the test mode, the configuration mode, and the measurement log review mode.
- the default clock mode is configured in one embodiment to display the time/date information as configured by the user 101 .
- the test mode includes operations for the user to perform blood glucose measurements
- the configuration mode includes functions for the user to select user preferences for configurable parameters of the glucose meter device 103
- the measurement log review mode allows reviewing of the glucose measurements stored in the meter device 103 .
- the meter device 103 when the glucose meter device 103 enters a non-clock mode of operation, the meter device 103 may be configured to display a self-test screen that illuminates all segments of the display unit in the user interface unit 203 prior to operating in the selected mode of operation. Moreover, the glucose meter device 103 may be configured to exit all operation modes after exceeding a predetermined period of non-activity/idle time (for example, 2 minutes) such as no switch activity, test strip activity, or display activity, for example.
- a predetermined period of non-activity/idle time for example, 2 minutes
- the central processing unit 206 of the glucose meter device 103 is configured such that, upon detection that there was a loss of power (for example, battery removal), the internal date is set to the last recorded date, and in the case where there is no valid recorded dates, the central processing unit 206 is configured to set the internal date to a predetermined date such as Jan. 1, 2002, for example.
- the internal time in one embodiment is reset to 12:00 am until a further time when the user resets the internal time.
- the blood sample test data collected during the period of power loss is configured to be flagged with a “lost time” flag and the corresponding lost power internal date and time discussed above.
- the user may be prompted (e.g., blinking signals displayed on the user interface unit 203 ) to reset the time and date information in the default clock mode.
- the correct insertion of the test strip 102 ( FIG. 1 ) engaged into the test strip connector unit 202 of the meter device 103 is detected, and upon removal of the test strip 102 , the meter device 103 is configured to enter the default operation mode.
- the glucose meter device 103 may be configured to automatically enter into the test mode of operation upon the correct insertion of the test strip 102 .
- the glucose meter device 103 may be configurable to enable manual initiation of the test mode of operation (such as, for example, by the user's manual operation of the test mode switch (not shown) of the meter device 103 .
- the glucose meter device 103 is configured to generate and output a corresponding respective message as such.
- faulty operation includes, but not limited to, the detection of a used test strip, insufficient blood sample on the test strip, incorrect insertion of the test strip into the test strip connector unit 202 of the meter device 103 , or when the coulometer circuits are not ready for sample processing.
- the outputted message to the user alerting of the faulty operation may include an audible sound, a visual display, or a combination of both.
- the glucose meter device 103 Upon successfully collecting sufficient blood sample for processing from the user 101 ( FIG. 1 ), the glucose meter device 103 is configured to process the collected sample, and to generate a corresponding blood glucose data for output display to the user 101 on the user interface unit 203 .
- the blood glucose data may be, for example, displayed in units of mg/dL or in units of mmol.
- the meter device 103 may also be configured to display the time and date information corresponding to the blood glucose level test.
- the central processing unit 206 is further configured to store the processed and displayed blood glucose data in the storage unit 207 .
- the user 101 may select and input certain predetermined parameters into the glucose meter device 103 to configure the meter device 103 for subsequent use thereafter.
- configurable parameters include the displayed date and time information, the alarm settings on the glucose meter device 103 , the preferred display format for data display on the display unit of the user interface unit 203 in the meter device 103 , the concentration unit of the generated glucose level, and an average glucose level information based on a user selected number of days such as 14-day or 30 day average of stored results.
- the glucose meter device 103 is configured to display a glucose summary (that is, the average glucose level information) of stored results, as well as other parameters such as the number of measurements incorporated into the displayed average level, and a visual indication to the user that the displayed data is the average glucose level information, and not a specific sampled glucose level data.
- the glucose meter device 103 may be configured to enter the measurement log review mode of operation upon the operation of the mode switch (in the user interface unit 203 ) while the meter device 103 is in the default clock mode.
- the glucose meter device 103 may be configured so that a “LO” is displayed for measured glucose values which are below 20 mg/dL, and in contrast, a “HI” is displayed when the measured glucose value exceeds 500 mg/dL. Furthermore, the meter device 103 may be configured to display the processed glucose level within approximately 15 seconds from the sampling of the corresponding blood for samples below 200 mg/dL when measured at room temperature and humidity.
- FIG. 3 illustrates the glucose meter device of FIG. 2 in accordance with one embodiment of the present invention.
- the glucose meter device 103 includes a housing 307 which substantially encases the meter device 103 .
- the glucose meter device 103 may be physically configured such that it is 3.12 inches in length, 2.25 inches in width and 0.85 inches in height, with no more that 1.4 ounces in weight with the batteries installed.
- the material used for the housing 307 may comprise plastic, metal, polymer, or a combination of any suitable material which provides substantial physical integrity when subject to normal usage of the meter device 103 including occasional dropping and other physical impacts.
- a data port 301 which corresponds to the I/O interface unit 205 ( FIG. 2 ), and is configured to operatively couple to an external computer or data processing device to transfer data collected and processed by the glucose meter device 103 .
- the data port 301 in one embodiment may include one of a Universal Serial Bus (USB) port, an infrared data communication port, a Bluetooth communication port, and a Wi-Fi wireless data communication port (for example, IEEE 802.11 or its equivalents).
- a display screen 302 which may be configured to display the test results and other parameters and information such as time and data information and the like.
- the display screen 302 in one embodiment may include a built-in display backlight for use in low-light conditions, and may be configured to automatically switch on in low-light settings for a predetermined period of time (such as 1 minute, for example), or may be configured for manual user operation.
- the mode switch 303 may be operated by the user to toggle between different operation modes such as the test mode, and the clock mode (default), configuration mode, and the measurement log review mode, each discussed above.
- the configuration switch 304 may be configured to, for example, mark a test result as control solution, change the test strip code, time and alarm settings, the output sound options, date information, the measurement unit information, and for review of the stored sample results. Also, the configuration switch 304 may also be depressed to silence the output of an alarm.
- the light switch 305 is configured to control the operation of the backlight of the display screen 302 , as well as the flashlight function of the meter device 103 .
- a test strip port 306 is additionally provided on the housing 307 of the glucose meter device 103 , and is configured to receive the insertion of a test strip 308 .
- the test strip port 306 substantially corresponds to the test strip connector unit 202 shown in FIG. 2 .
- a light source such as a light emitting diode (LED) and the like which is configured to switch on and off under the operation of, for example, the light switch 305 , or alternatively, in accordance with a certain operations of the glucose meter device 103 such as, for example, the detection of the test strip 308 at the opening of the test strip port 306 .
- LED light emitting diode
- the test strip 308 may include a top portion 309 and a bottom portion 310 such that the top portion 309 is configured to be inserted into the test strip port 306 of the glucose meter device 103 , while the bottom portion 310 of the test strip 308 substantially comprises the blood sample target areas for the user to apply the blood sample or a control solution thereto.
- the test strip 308 is a Freestyle® Test Strip currently available from the assignee of the present application, TheraSense, Inc. of Alameda, Calif.
- FIGS. 4A and 4B illustrate the display screen of the glucose meter device in accordance with one embodiment of the present invention.
- the display screen 302 of the glucose meter device shown in FIG. 3 includes a plurality of visual representation of display information.
- the check owner's manual symbol 401 is displayed to alert the user 101 ( FIG. 1 ) to refer to the manual of the glucose meter device, and may be displayed on the display screen 302 when, for example, the meter device detects LO or HI blood glucose level, out of temperature range results, and low power state.
- the control solution test result symbol 302 is displayed to alert the user that the user has marked a test result as a control solution test.
- the message area 403 of the display screen 302 may be configured to display information such as the date information, the time information, the number of tests performed, and other information related to the operation and function of the glucose meter device.
- a test result area 406 which is configured to display the resulting glucose level determined from the corresponding blood sample.
- a battery symbol 405 and a memory mode symbol 404 are also shown in FIG. 4A , where the battery symbol 405 is configured to be illuminated when the power supply level (e.g., the battery level) is detected to be lower than the optimum operating level, and to alert the user 101 ( FIG. 1 ) to replace the same.
- the memory mode symbol 404 is configured to display to the user 101 ( FIG. 1 ) that the test result displayed in the rest result area 406 has been stored in the memory (the storage unit 207 ( FIG. 2 )) of the glucose meter device.
- the memory capacity of the meter device may store up to approximately 250 blood glucose test results.
- the display screen 302 may further be configured to display a blood drop symbol and a test strip symbol 414 , which are configured to operate in tandem to alert the user that the meter device is ready to apply the blood sample or the control solution.
- the unit symbol 413 is configured to appear with the test result data displayed in the test result area 406 of the display screen 302 when the blood sample has been successfully collected and a corresponding glucose level has been determined based on the collected blood sample.
- the date setup symbol 407 on the display screen 302 may be displayed in the configuration mode when the user is setting the date information of the glucose meter device.
- a check and set test strip code symbol 408 is provided on the display screen 302 to alert the user to check and set the test strip code, while the thermometer symbol 409 is displayed on the display screen 302 when the meter is operating in a temperature range that is beyond that which will permit an accurate reading.
- a set of sound level symbols 410 are provided in one embodiment to indicate whether the glucose meter device audible output alert mode is at a predetermined setting (for example, high, low or off), while the time set symbol 411 appears on the display screen 302 in the default clock mode when the user is setting the time information on the glucose meter device.
- the data average symbol 412 is configured to appear on the display screen 302 with a glucose reading that is the average value of the readings from the past 14 days, for example or any other predetermined time period as may be established by the meter device as a default mode or by the user during calibration stage of the glucose meter device.
- the current date is continuously displayed on the upper line (top row of five 7-segment digits) of message area 403
- the current time is continuously displayed on the lower line (bottom row of five 7-segment digits) of message area 403 .
- the numerical result is shown in the test result area 406 .
- the date and time information are displayed in a different area of display screen 302 from the glucose test results, and with different sized digits (preferably smaller as shown).
- the test result area 406 be offset from the center of display screen 302 , even more preferably located in a corner of the display screen 302 as shown.
- the display screen 302 of the glucose meter device in accordance with one embodiment of the present invention may be configured to display information corresponding to the glucose tests and the processed results in a easy and intuitive manner.
- FIG. 5 is a flowchart illustrating the procedure for performing a blood glucose test using the glucose meter device in accordance with one embodiment of the present invention.
- the glucose meter device detects the insertion of a test strip 102 in the test strip connector unit 202 ( FIG. 2 ).
- the meter device 103 is powered on, and at step 502 , the inserted test strip is verified and a self test of the meter device is performed.
- a system check illumination briefly lights up the entire display screen 302 and the various data symbols and areas included therein, and thereafter, in step 503 the user 101 is prompted to input a code number which corresponds to the calibration code number preassigned to the test strip inserted into the meter device.
- the blood drop and test strip symbols 414 are displayed on the display screen 302 to prompt the user to apply the blood sample to the test strip.
- the test strip acts like a sponge and pulls the blood into the strip through its edges.
- it is determined whether the collected blood sample amount is sufficient to generate a corresponding blood glucose level If it is determined at step 505 that the collected blood sample amount is not sufficient to generate the corresponding blood glucose level, then the procedure returns to step 504 to prompt the user to further apply the blood sample to the test strip.
- the user 101 ( FIG. 1 ) is notified as such in step 506 by an audible alert sound output via the user interface 203 (e.g., through an output speaker), and/or by visual display on the display screen 302 ( FIG. 3 ).
- the glucose meter device is then configured at step 507 to determine the glucose value corresponding to the detected blood sample, and thereafter at step 508 , to display the resulting glucose value on the display screen 302 ( FIG. 3 ), and to store the generated glucose value in the storage unit 207 ( FIG. 2 ).
- the glucose meter device may be configured to output a single audible alert notification when the collected blood sample is sufficient to generate the corresponding glucose level information, and to output a double audible alert notification when the glucose level information has been determined and displayed on display screen 302 .
- the time and date information may also be displayed on the display screen 302 in connection with the generated glucose level information.
- the glucose meter device may be configured such that upon power on procedure, the light source (e.g., an LED) at the test strip port 306 ( FIG. 3 ) is configured to illuminate at substantially 50% of the full intensity to permit the introduction of the test strip 102 into the test strip port 306 . Thereafter, when the test strip 102 is fully inserted into the test strip port 306 of the glucose meter device, the light source at the test strip port 306 , and alternatively, in addition to the backlight of the display screen 302 , is illuminated at the full intensity level to indicate blood sample collection operation.
- the light source e.g., an LED
- the intensity of the light source at the test strip port 306 (and alternatively, as well as the backlight of the display screen 302 ) are reduced substantially to the 50% level again, and when the test strip is removed from the test strip port 306 , the light source is configured to shut off completely.
- the light source e.g., the LED
- the battery life of the glucose meter device may be prolonged since the pulsed LED light source requires significantly less power (and thus draining the battery at a much slower rate) than when the LED light source is maintained at the on position.
- the central processing unit 206 of the glucose meter device 103 may be configured to control the switching on and off of the light source as well as the level of light intensity by, for example, adjusting the duty cycle and the period during which the light source is configured to be turned on.
- FIG. 6 illustrates the output LED power level as a function of the power state in accordance with one embodiment of the present invention. As can be seen from the Figure, 50% duty cycle as shown on the X-axis corresponds to approximately 80% of the output power level for the LED light source.
- a yellow/green LED is used for the test strip light, such as part number LT 19209-40 manufactured by Ledtech Electronics Corporation located in Hsin-Tien, Taiwan, or part number ZSG56W manufactured by SunLED Co. located in Kowloon, Hong Kong.
- These LEDs provide a light having a peak wavelength of about 575 nanometers, which has been found to provide optimal contrast between various colors of blood against various skin pigments in low light conditions. More specifically, using a yellow-green LED with peak wavelength of 570 nanometers in one embodiment provided optional contrast between the various colors of blood against the skin pigments in low light conditions.
- the test light LED is pulsed faster than 60-100 hertz so that it appears to the human eye that it is continuously on without flickering, most preferably 3 or 7 khz. It has been discovered that a 10% duty cycle with the LEDs specified above provides the most desired balance between light intensity and battery power savings. A brighter light output than this can be disruptive in certain low light settings, such as a movie theater, and can inhibit inconspicuous blood glucose testing.
- the glucose meter device may be configured such that the backlight on the display screen 302 is turned on when the test strip 102 is inserted into the test strip port 306 of the meter device. Thereafter, the backlight is configured to turn off when the blood drop and test strip symbols 414 are displayed in tandem to alert the user that the meter device is ready to apply the blood sample or the control solution.
- the light source at the test strip port 306 e.g., the LED light source
- the light source at the test strip port 306 is illuminated so that the user may light up the test strip 102 and the sample acquisition site on the user 101 if desired.
- step 505 the meter device detects a sufficient level of blood sample on the test strip 102 (i.e., step 505 ( FIG. 5 ) is successfully performed)
- the light source at the test strip port 306 is disabled, and the backlight on the display screen 302 is once again illuminated so that the user may view the corresponding glucose level generated from the collected blood sample.
- pressing the light button 305 powers on either the display backlight or the test strip light, depending on what mode the meter is in. Pressing the light button 305 in non-test modes powers on the display backlight. The display backlight goes out when light button 305 is pressed again, or when the meter is inactive for 5 seconds. Pressing the light button when the blood drop and test strip symbols appear on the display screen powers on the test strip light. The test strip light goes out when the light button 305 is pressed again, or the meter receives the correct amount of blood for the test (i.e. the test strip is filled), or after 60 seconds of meter inactivity, or when the test strip is removed from the meter.
- the test strip light cannot be activated unless there is a test strip inserted in the test strip port. If either the test strip light or the display backlight is used during the test mode, the backlight preferably powers on to show the test results after the measurement is complete.
- the glucose meter is powered by two coin cell batteries of a common size, such as CR2032. It is also preferable that one of the batteries is dedicated to powering the test strip light and display backlight, and the other is dedicated to powering the meter's processor and other functions. It may also be desirable to allow the meter to be placed in a “shelf mode” after final testing at the factory such that even with batteries inserted, nothing is shown on the display and the processor is in an energy saving sleep mode until one of the buttons is pressed or a test strip is inserted in the meter to resume normal operation.
- a common size such as CR2032. It is also preferable that one of the batteries is dedicated to powering the test strip light and display backlight, and the other is dedicated to powering the meter's processor and other functions. It may also be desirable to allow the meter to be placed in a “shelf mode” after final testing at the factory such that even with batteries inserted, nothing is shown on the display and the processor is in an energy saving sleep mode until one of the buttons is
- the glucose meter device 103 is configured such that it is simple, intuitive and easy to use, permitting the user to perform the tests relatively discreetly, and is also easily used by third parties such as the user's physician, nurse, care giver or family member. Moreover, given the compact physical configuration, the glucose meter device 103 is substantially small, compact, sleek and readily portable by the user.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Human Computer Interaction (AREA)
- Ecology (AREA)
- Optics & Photonics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
A blood glucose meter having a compact housing, a display unit disposed on the housing, the display unit including a display light source to illuminate the display unit, an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter, and a power source provided within the housing for providing power to the blood glucose meter, where the housing includes a port integrated on said housing configured to receive a blood glucose test strip, and corresponding methods of measuring blood glucose meter is provided.
Description
- This application is a continuation application of pending U.S. patent application Ser. No. 10/861,626 filed Jun. 4, 2004, which claims priority under 35 USC §119 to Provisional Application No. 60/478,436 filed Jun. 12, 2003, entitled “Method and Apparatus for Providing Power Management in Data Communication Systems”, the disclosures of each of which are incorporated herein by reference for all purposes, and each of which are assigned to assignee, Abbott Diabetes Care, Inc., of Alameda, Calif.
- The present invention relates to data monitoring systems. More specifically, the present invention relates to portable analyte monitoring systems. More specifically, the present invention relates to a compact, blood glucose meter for use in a glucose monitoring system to self-monitor glucose level in whole blood, as an aid to disease management, and also by healthcare professionals as an aid to monitor the effectiveness of diabetes treatment.
- The market for glucose monitoring systems in the United States as well as globally is rapidly increasing, as better health education and early detection of diabetic conditions through regular check ups have increased the percentage of the diabetic population who undertake the task of monitoring their diet and daily activities based on the detected level of blood glucose using glucose monitoring systems. One group of such rapidly increasing segment of the population is children with diabetic conditions who are advised to monitor their blood glucose levels.
- While miniaturization has been a factor of recent designs in the glucose monitoring systems and the glucose meters, the physical constraints of the components of such systems have established a certain size limitation. As such, the larger and bulkier the device, the less desirable and convenient for the device to be carried around or used and operated by the patients, especially children.
- In view of the foregoing, in accordance with the various embodiments of the present invention, there is provided a blood glucose meter which is designed to be substantially more compact than presently available commercial blood glucose meters, which configuration that is much more amenable to usage and portage by younger diabetic patients such as children.
- More specifically, in one aspect of the invention, the blood glucose meter is configured to include a LCD backlight and a flashlight features which will assist the patient in reading the metered glucose level in low-light testing areas such as in theaters, low ambient light restaurants, areas, outdoors during non-daylight times and so on, as well as a light source to guide the insertion and removal of the test strip, which may include the usage of a light emitting diode. Indeed, as the light source (e.g., the LED) may be pulsed and still display substantially the same light output as one which is turned on in steady state, the battery life of the glucose meter device may be prolonged since the pulsed LED light source requires significantly less power (and thus draining the battery at a much slower rate) than when the LED light source is maintained at the on position. Indeed, in one embodiment, the central processing unit of the glucose meter device may be configured to control the switching on and off of the light source as well as the level of light intensity by, for example, adjusting the duty cycle and the period during which the light source is configured to be turned on.
- Additionally, in accordance with a further aspect of the invention, the blood glucose meter may include a numerically displayed clock with a date display which may be visible when the meter is not in use. Moreover, the clock feature in yet a further embodiment of the present invention may include an alarm which would allow the users to set alarm reminder for performing blood glucose level testing, where the alarm feature may include one or a combination of an auditory alarm, a visual alarm alert, and a vibration alert mode.
- Indeed, a blood glucose meter in accordance with one embodiment of the present invention includes a compact housing for a blood glucose meter, a display unit disposed on the housing, the display unit configured to display information related to the blood glucose meter, an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter, and a power source provided within the housing for providing power to the blood glucose meter.
- The display unit may include one of a liquid crystal display (LCD), a touch sensitive screen, and a plasma display unit.
- The display unit may also include a light source to illuminate the display unit, where the light source may be configured to provide a backlight function and a flashlight function of the display unit.
- The light source in one embodiment may be configured to be pulsed at a frequency greater than 60-100 Hertz. Moreover, the light source may further configured to have a peak wavelength of approximately 570 nanometers.
- In one embodiment, the light source may include a light emitting diode (LED), and more specifically, a yellow-green LED.
- In a further embodiment, the housing may include a port integrated on the housing configured to receive a blood glucose test strip.
- The port may include a light source that may be configured to substantially illuminate the port to assist in the insertion and/or removal of the blood glucose test strip.
- In yet another embodiment, the display unit may be configured to illuminate upon detection of a blood glucose test strip insertion into the port. Further, the display unit may be configured to remain illuminated until the test strip is removed from the port.
- The input unit in one embodiment may include an on/off switch.
- A blood glucose meter in accordance with another embodiment includes a compact housing for a blood glucose meter, a display unit disposed on the housing, the display unit including a display light source to illuminate the display unit, an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter, and a power source provided within the housing for providing power to the blood glucose meter, where the housing includes a port integrated on said housing configured to receive a blood glucose test strip.
- The port in one embodiment may include a port light source, the port light source configured to substantially illuminate the port to assist in the insertion and/or removal of the blood glucose test strip.
- Additionally, in an alternate embodiment, the port light source may be integrated with the display light source.
- A method of measuring blood glucose level in accordance with yet another embodiment of the present invention includes the steps of providing a compact housing, disposing a display unit on the housing, the display unit including a display light source to illuminate the display unit, disposing an input unit on the housing, the input unit configured to provide input functions for the blood glucose meter, providing a power source within the housing for providing power to the blood glucose meter, where the housing includes a port integrated on said housing configured to receive a blood glucose test strip.
- These and other features and advantages of the present invention will be understood upon consideration of the following detailed description of the invention and the accompanying drawings.
- Applicants herein incorporate by reference U.S. Pat. No. 6,616,819 issued Sep. 9, 2003 entitled “Small Volume In Vitro Analyte Sensor and Methods”, U.S. Pat. No. 6,560,471 issued on May 6, 2003 entitled “Analyte Monitoring Device and Methods of Use”, and U.S. Provisional Application No. 60/437,374 filed Dec. 31, 2002 and U.S. Published Application No. 2004/0186365 published Sep. 23, 2004 both entitled “Continuous Glucose Monitoring System and Methods of Use”, each assigned to the Assignee of the present application for all purposes.
-
FIG. 1 is a block diagram illustrating an overall glucose monitoring system in accordance with one embodiment of the present invention; -
FIG. 2 is a block diagram illustrating a glucose meter device shown inFIG. 1 in accordance with one embodiment of the present invention; -
FIG. 3 illustrates the glucose meter device ofFIG. 2 in accordance with one embodiment of the present invention; -
FIGS. 4A and 4B illustrate the display screen of the glucose meter device in accordance with one embodiment of the present invention; -
FIG. 5 is a flowchart illustrating the procedure for performing a blood glucose test using the glucose meter device in accordance with one embodiment of the present invention; and -
FIG. 6 illustrates the output LED power level as a function of the power state in accordance with one embodiment of the present invention. -
FIG. 1 is a block diagram illustrating an overall glucose monitoring system in accordance with one embodiment of the present invention. Referring to the Figure, theglucose monitoring system 100 in accordance with one embodiment includes aglucose meter device 103 configured to receive atest strip 102 which is used to collect the blood sample for determining the blood glucose level of theuser 101. Thelancing device 104 is used to draw the blood sample from theuser 101 to be collected onto thetest strip 102. In one embodiment, thelancing device 104 may be used on the user's fingers, forearm, upper arm, hand, thigh or calf, for example. Moreover, theglucose meter device 103 and thesystem 100 is configured such that a very small blood sample size such as, for example, approximately 0.3 microliter of sample blood, is necessary to determine a corresponding blood glucose level. - As can be further seen from
FIG. 1 , theglucose meter device 103 may be operatively coupled to anexternal computer 105 which may include, in one embodiment, a server terminal connected to a data network, a stand along desktop or laptop computer for use by the user's physician or care provider (or the user herself), a personal digital assistant (PDA) which is operatively configured to store and/or further, to communicate with a data network to transmit and receive patient data related to the glucose level detected from the collected blood sample, for further diagnosis, analysis and the like. - In one embodiment, the
user 101 may provide the configuration parameters as well as calibration code to theglucose meter device 103, while theglucose meter device 103 may be configured to output signal prompts to theuser 101 such as to indicate a sample fill signal and a sample result signal, and further, to output display the resulting measured blood glucose level from the sampled blood from theuser 101. Furthermore, after theuser 101 is lanced with thelancing device 104 to generate sufficient amount of sample blood, thetest strip 102 is provided in contact thereto (i.e., to the sample blood) while thetest strip 102 is operatively coupled to theglucose meter device 103. In this manner, theglucose meter device 103 may in one embodiment be configured to alert the user that the amount of blood sample on thetest strip 102 is sufficient to determine the corresponding blood glucose level. - In one aspect of the present invention, the
glucose meter device 103 may be configured to make clinical measurements of glucose in whole blood in the range for approximately 20 to 500 mg/dL. Furthermore, as discussed in further detail below, theglucose meter device 103 may be configured to include a display unit which is configured to operate as a user interface to visually interact with theuser 101 to prompt for data input, or alternatively, to provide information to theuser 101 corresponding to the user's operation of one or more functions of theglucose meter device 103. In one embodiment, the display unit of theglucose meter device 103 may include a LCD display screen which may further be configured, in an alternate embodiment to include a touch-sensitive pad so as to allow theuser 101 to input data therethrough. Moreover, in a further embodiment of the present invention, the display unit of theglucose meter device 103 may be configured to include a backlight feature which would permit theuser 101 to operate theglucose meter device 103 in a dark ambient setting such as in a theater, outdoor at night, and the like. -
FIG. 2 is a block diagram illustrating a glucose meter device shown inFIG. 1 in accordance with one embodiment of the present invention. Referring toFIG. 2 , theglucose meter device 103 in accordance with one embodiment of the present invention includes acentral processing unit 206 operatively coupled to a digitaldata processing unit 204. Thecentral processing unit 206 is further operatively coupled to astorage unit 207 which, in one embodiment, may include one or more of a data storage unit, a random access memory unit and a read-only memory unit. As can be further seen from the Figure, the digitaldata processing unit 204 is further operatively coupled to an input/output (I/O)interface unit 205 which, in one embodiment, is configured to interface with the external computer 105 (FIG. 1 ). - Moreover, in the
glucose meter device 103, there is provided an analogdata processing unit 201 which is configured to detect and process analog signals and which is further operatively coupled to the digitaldata processing unit 204 for digital data processing of the detected and processed analog signals received from the analogdata processing unit 201 in one embodiment of the present invention. Referring back toFIG. 2 , the analogdata processing unit 201 of theglucose meter device 103 is further configured to operatively couple to a teststrip connector unit 202 which is configured to engage with a test strip 102 (FIG. 1 ) when inserted into theglucose meter device 103. Thereafter, the analogdata processing unit 201 as mentioned above is configured to detect the signal level from the collected blood sample received from the test strip 102 (FIG. 1 ) via the teststrip connector unit 202, and to transmit that detected and analog processed data to the digitaldata processing unit 204 for further data processing. - Referring yet again to
FIG. 2 , there is also shown auser interface unit 203 provided to theglucose meter device 103. As can be seen, theuser interface unit 203 is operatively coupled to the user 101 (FIG. 1 ) to receive input data or instructions therefrom, or alternatively, to output the processed and/or generated information to theuser 101. More specifically, in accordance with one embodiment of the present invention, theuser interface unit 203 may include a display unit, an input device such as an input keypad, or any other equivalent device which may provide substantially the same functionality as the input device such as an input keypad. - Additionally, the display unit of the
user interface unit 203 may include an LCD display unit which is also capable of providing backlighting so as to permit the user to view the displayed information on the backlit display unit of theuser interface unit 203 in dark ambient settings. Moreover, in an alternate embodiment of the present invention, theuser interface unit 203 may also include a flashlight feature which, upon activation by the user, is configured to emit a consistent light beam to assist the user in the operation of theglucose meter device 103 and/or the lancingdevice 104 in dark surroundings. Further, the flashlight feature may also be configured to include a timer function such that the flashlight is configured, in one embodiment, to automatically turn off after a predetermined period of time has elapsed. In this manner, the power source for the glucose meter device 103 (FIG. 1 ) may be conserved in the cases where theuser 101 leaves the flashlight feature on theglucose meter device 103 on. - Referring yet again to
FIG. 2 , theuser interface unit 203 in accordance with a further embodiment of the present invention may include a speaker unit configured to output audio signals. More specifically, in one aspect of the present invention, theuser 101 may be alerted or reminded of one or more time specific events or reminder such as the next time theuser 101 needs to take a blood glucose level measurement. Rather than relying solely upon the user's memory, theglucose meter device 103 may be configured with an alarm feature operatively engaged with a timer function such that, in addition to displaying the current time information on the display unit, theglucose meter device 103 may be configured to generate and output an audible sound for each specific event or reminder which theuser 101 has pre-programmed into theglucose meter device 103. Moreover, in a further embodiment, the audible alarm output (or a series or audible tones as may be selected by the user) may be simultaneously generated with the backlight feature of theglucose meter device 103 such that for each of use, the user is able to view information displayed on the display unit of theuser interface unit 203 substantially immediately without the need to perform extra steps such as turning on the backlight function of theglucose meter device 103. In the preferred embodiment, the meter allows the user to set up to four separate alarms to go off every 24 hours at a particular time to remind the user to test her blood glucose level. Preferably, the volume of each alarm may be set independently. - Referring back yet again to
FIG. 2 , in one embodiment of the present invention, thecentral processing unit 206 is configured to perform a plurality of functions to maintain, calibrate and operate theglucose meter device 103. More specifically, upon power up of theglucose meter device 103 when the power source such as the batteries, are placed in the respective section of the device housing, under the control of thecentral processing unit 206, theglucose meter device 103 is configured to perform a power on/reset sequence to initialize the various aforementioned components of theglucose meter device 103 to the necessary configuration settings. Upon successful completion of the power on/reset sequence, thecentral processing unit 206 is then configured to enter theglucose meter device 103 into a default operation mode (for example, the clock mode) as discussed in further detail below. More specifically, in one embodiment, thecentral processing unit 206 is configured to access thestorage unit 207 to retrieve the corresponding power on/reset sequence instruction set from the storage unit 207 (for example, in the ROM portion and/or the RAM portion thereof). Moreover, in one embodiment, thecentral processing unit 206 is configured to perform and complete the aforementioned power on/reset sequence within approximately 500 mseconds. - In one aspect, the
central processing unit 206 of theglucose meter device 103 may be configured for operating themeter device 103 in one of the following modes of operation—the clock mode (the default mode discussed above), the test mode, the configuration mode, and the measurement log review mode. The default clock mode is configured in one embodiment to display the time/date information as configured by theuser 101. The test mode includes operations for the user to perform blood glucose measurements, the configuration mode includes functions for the user to select user preferences for configurable parameters of theglucose meter device 103, and the measurement log review mode allows reviewing of the glucose measurements stored in themeter device 103. - In one embodiment, when the
glucose meter device 103 enters a non-clock mode of operation, themeter device 103 may be configured to display a self-test screen that illuminates all segments of the display unit in theuser interface unit 203 prior to operating in the selected mode of operation. Moreover, theglucose meter device 103 may be configured to exit all operation modes after exceeding a predetermined period of non-activity/idle time (for example, 2 minutes) such as no switch activity, test strip activity, or display activity, for example. - Additionally, the
central processing unit 206 of theglucose meter device 103 is configured such that, upon detection that there was a loss of power (for example, battery removal), the internal date is set to the last recorded date, and in the case where there is no valid recorded dates, thecentral processing unit 206 is configured to set the internal date to a predetermined date such as Jan. 1, 2002, for example. Likewise, upon detection of the loss of power, the internal time in one embodiment is reset to 12:00 am until a further time when the user resets the internal time. Moreover, the blood sample test data collected during the period of power loss is configured to be flagged with a “lost time” flag and the corresponding lost power internal date and time discussed above. Upon re-application of power to theglucose meter device 103, in one embodiment, the user may be prompted (e.g., blinking signals displayed on the user interface unit 203) to reset the time and date information in the default clock mode. - Referring still again to
FIG. 2 , in the test mode of operation of theglucose meter device 103 in one embodiment, the correct insertion of the test strip 102 (FIG. 1 ) engaged into the teststrip connector unit 202 of themeter device 103 is detected, and upon removal of thetest strip 102, themeter device 103 is configured to enter the default operation mode. In this manner, theglucose meter device 103 may be configured to automatically enter into the test mode of operation upon the correct insertion of thetest strip 102. Alternatively, theglucose meter device 103 may be configurable to enable manual initiation of the test mode of operation (such as, for example, by the user's manual operation of the test mode switch (not shown) of themeter device 103. - During the test mode of operation, if a faulty operation is detected, the
glucose meter device 103 is configured to generate and output a corresponding respective message as such. Examples of such faulty operation includes, but not limited to, the detection of a used test strip, insufficient blood sample on the test strip, incorrect insertion of the test strip into the teststrip connector unit 202 of themeter device 103, or when the coulometer circuits are not ready for sample processing. The outputted message to the user alerting of the faulty operation may include an audible sound, a visual display, or a combination of both. - Upon successfully collecting sufficient blood sample for processing from the user 101 (
FIG. 1 ), theglucose meter device 103 is configured to process the collected sample, and to generate a corresponding blood glucose data for output display to theuser 101 on theuser interface unit 203. The blood glucose data may be, for example, displayed in units of mg/dL or in units of mmol. Moreover, in one embodiment, themeter device 103 may also be configured to display the time and date information corresponding to the blood glucose level test. Moreover, thecentral processing unit 206 is further configured to store the processed and displayed blood glucose data in thestorage unit 207. - Referring still to
FIG. 2 , in the configuration mode of operation, in one embodiment of the present invention, theuser 101 may select and input certain predetermined parameters into theglucose meter device 103 to configure themeter device 103 for subsequent use thereafter. For example, such configurable parameters include the displayed date and time information, the alarm settings on theglucose meter device 103, the preferred display format for data display on the display unit of theuser interface unit 203 in themeter device 103, the concentration unit of the generated glucose level, and an average glucose level information based on a user selected number of days such as 14-day or 30 day average of stored results. - In the measurement log review mode of operation discussed above, the
glucose meter device 103 is configured to display a glucose summary (that is, the average glucose level information) of stored results, as well as other parameters such as the number of measurements incorporated into the displayed average level, and a visual indication to the user that the displayed data is the average glucose level information, and not a specific sampled glucose level data. As will be discussed in further detail below, theglucose meter device 103 may be configured to enter the measurement log review mode of operation upon the operation of the mode switch (in the user interface unit 203) while themeter device 103 is in the default clock mode. - In one embodiment, the
glucose meter device 103 may be configured so that a “LO” is displayed for measured glucose values which are below 20 mg/dL, and in contrast, a “HI” is displayed when the measured glucose value exceeds 500 mg/dL. Furthermore, themeter device 103 may be configured to display the processed glucose level within approximately 15 seconds from the sampling of the corresponding blood for samples below 200 mg/dL when measured at room temperature and humidity. -
FIG. 3 illustrates the glucose meter device ofFIG. 2 in accordance with one embodiment of the present invention. As shown, theglucose meter device 103 includes ahousing 307 which substantially encases themeter device 103. In one embodiment, theglucose meter device 103 may be physically configured such that it is 3.12 inches in length, 2.25 inches in width and 0.85 inches in height, with no more that 1.4 ounces in weight with the batteries installed. Moreover, the material used for thehousing 307 may comprise plastic, metal, polymer, or a combination of any suitable material which provides substantial physical integrity when subject to normal usage of themeter device 103 including occasional dropping and other physical impacts. - Also shown in
FIG. 3 is adata port 301 which corresponds to the I/O interface unit 205 (FIG. 2 ), and is configured to operatively couple to an external computer or data processing device to transfer data collected and processed by theglucose meter device 103. Thedata port 301 in one embodiment may include one of a Universal Serial Bus (USB) port, an infrared data communication port, a Bluetooth communication port, and a Wi-Fi wireless data communication port (for example, IEEE 802.11 or its equivalents). - Referring back to
FIG. 3 , provided on thehousing 307 is adisplay screen 302 which may be configured to display the test results and other parameters and information such as time and data information and the like. Thedisplay screen 302 in one embodiment may include a built-in display backlight for use in low-light conditions, and may be configured to automatically switch on in low-light settings for a predetermined period of time (such as 1 minute, for example), or may be configured for manual user operation. - Also shown in
FIG. 3 are three input switches—amode switch 303, theconfiguration switch 304, and thelight switch 305. In one embodiment, themode switch 303 may be operated by the user to toggle between different operation modes such as the test mode, and the clock mode (default), configuration mode, and the measurement log review mode, each discussed above. Theconfiguration switch 304 may be configured to, for example, mark a test result as control solution, change the test strip code, time and alarm settings, the output sound options, date information, the measurement unit information, and for review of the stored sample results. Also, theconfiguration switch 304 may also be depressed to silence the output of an alarm. Finally, thelight switch 305 is configured to control the operation of the backlight of thedisplay screen 302, as well as the flashlight function of themeter device 103. - Referring yet again to
FIG. 3 , atest strip port 306 is additionally provided on thehousing 307 of theglucose meter device 103, and is configured to receive the insertion of atest strip 308. In one embodiment, thetest strip port 306 substantially corresponds to the teststrip connector unit 202 shown inFIG. 2 . Also provided on thetest strip port 306 is a light source such as a light emitting diode (LED) and the like which is configured to switch on and off under the operation of, for example, thelight switch 305, or alternatively, in accordance with a certain operations of theglucose meter device 103 such as, for example, the detection of thetest strip 308 at the opening of thetest strip port 306. As can be further seen, thetest strip 308 may include atop portion 309 and abottom portion 310 such that thetop portion 309 is configured to be inserted into thetest strip port 306 of theglucose meter device 103, while thebottom portion 310 of thetest strip 308 substantially comprises the blood sample target areas for the user to apply the blood sample or a control solution thereto. In one embodiment, thetest strip 308 is a Freestyle® Test Strip currently available from the assignee of the present application, TheraSense, Inc. of Alameda, Calif. -
FIGS. 4A and 4B illustrate the display screen of the glucose meter device in accordance with one embodiment of the present invention. Referring to the Figures, thedisplay screen 302 of the glucose meter device shown inFIG. 3 includes a plurality of visual representation of display information. For example, as shown inFIG. 4A , the check owner'smanual symbol 401 is displayed to alert the user 101 (FIG. 1 ) to refer to the manual of the glucose meter device, and may be displayed on thedisplay screen 302 when, for example, the meter device detects LO or HI blood glucose level, out of temperature range results, and low power state. The control solutiontest result symbol 302 is displayed to alert the user that the user has marked a test result as a control solution test. - Referring back to
FIG. 4A , themessage area 403 of thedisplay screen 302 may be configured to display information such as the date information, the time information, the number of tests performed, and other information related to the operation and function of the glucose meter device. There is also provided in the display screen 302 atest result area 406 which is configured to display the resulting glucose level determined from the corresponding blood sample. Also shown inFIG. 4A are abattery symbol 405 and amemory mode symbol 404, where thebattery symbol 405 is configured to be illuminated when the power supply level (e.g., the battery level) is detected to be lower than the optimum operating level, and to alert the user 101 (FIG. 1 ) to replace the same. Thememory mode symbol 404 on the other hand, is configured to display to the user 101 (FIG. 1 ) that the test result displayed in therest result area 406 has been stored in the memory (the storage unit 207 (FIG. 2 )) of the glucose meter device. In one embodiment, the memory capacity of the meter device may store up to approximately 250 blood glucose test results. - Referring now to
FIG. 4B , thedisplay screen 302 may further be configured to display a blood drop symbol and atest strip symbol 414, which are configured to operate in tandem to alert the user that the meter device is ready to apply the blood sample or the control solution. Moreover, theunit symbol 413 is configured to appear with the test result data displayed in thetest result area 406 of thedisplay screen 302 when the blood sample has been successfully collected and a corresponding glucose level has been determined based on the collected blood sample. Thedate setup symbol 407 on thedisplay screen 302 may be displayed in the configuration mode when the user is setting the date information of the glucose meter device. - As further shown, a check and set test
strip code symbol 408 is provided on thedisplay screen 302 to alert the user to check and set the test strip code, while thethermometer symbol 409 is displayed on thedisplay screen 302 when the meter is operating in a temperature range that is beyond that which will permit an accurate reading. A set ofsound level symbols 410 are provided in one embodiment to indicate whether the glucose meter device audible output alert mode is at a predetermined setting (for example, high, low or off), while the time setsymbol 411 appears on thedisplay screen 302 in the default clock mode when the user is setting the time information on the glucose meter device. Finally, the dataaverage symbol 412 is configured to appear on thedisplay screen 302 with a glucose reading that is the average value of the readings from the past 14 days, for example or any other predetermined time period as may be established by the meter device as a default mode or by the user during calibration stage of the glucose meter device. - In the preferred embodiment of the present invention, when the
meter 103 is not otherwise in use, the current date is continuously displayed on the upper line (top row of five 7-segment digits) ofmessage area 403, and the current time is continuously displayed on the lower line (bottom row of five 7-segment digits) ofmessage area 403. As previously mentioned, immediately after a blood glucose test is completed, the numerical result is shown in thetest result area 406. In this preferred embodiment, the date and time information are displayed in a different area ofdisplay screen 302 from the glucose test results, and with different sized digits (preferably smaller as shown). Also, it is preferable that thetest result area 406 be offset from the center ofdisplay screen 302, even more preferably located in a corner of thedisplay screen 302 as shown. - In the manner described above, the
display screen 302 of the glucose meter device in accordance with one embodiment of the present invention may be configured to display information corresponding to the glucose tests and the processed results in a easy and intuitive manner. -
FIG. 5 is a flowchart illustrating the procedure for performing a blood glucose test using the glucose meter device in accordance with one embodiment of the present invention. Referring toFIGS. 2 and 5 , atstep 501, the glucose meter device detects the insertion of atest strip 102 in the test strip connector unit 202 (FIG. 2 ). In response to the detection of thetest strip 102 insertion, themeter device 103 is powered on, and atstep 502, the inserted test strip is verified and a self test of the meter device is performed. More specifically, atstep 502, a system check illumination briefly lights up theentire display screen 302 and the various data symbols and areas included therein, and thereafter, instep 503 theuser 101 is prompted to input a code number which corresponds to the calibration code number preassigned to the test strip inserted into the meter device. - After verifying the code number for the test strip, at
step 504, the blood drop and test strip symbols 414 (FIG. 4B ) are displayed on thedisplay screen 302 to prompt the user to apply the blood sample to the test strip. When the blood sample is in contact with the test strip, the test strip acts like a sponge and pulls the blood into the strip through its edges. Thereafter atstep 505, it is determined whether the collected blood sample amount is sufficient to generate a corresponding blood glucose level. If it is determined atstep 505 that the collected blood sample amount is not sufficient to generate the corresponding blood glucose level, then the procedure returns to step 504 to prompt the user to further apply the blood sample to the test strip. - On the other hand, if it is determined at
step 505 that the collected level of blood sample is sufficient to generate the corresponding blood glucose level, the user 101 (FIG. 1 ) is notified as such instep 506 by an audible alert sound output via the user interface 203 (e.g., through an output speaker), and/or by visual display on the display screen 302 (FIG. 3 ). The glucose meter device is then configured atstep 507 to determine the glucose value corresponding to the detected blood sample, and thereafter atstep 508, to display the resulting glucose value on the display screen 302 (FIG. 3 ), and to store the generated glucose value in the storage unit 207 (FIG. 2 ). - In one embodiment, the glucose meter device may be configured to output a single audible alert notification when the collected blood sample is sufficient to generate the corresponding glucose level information, and to output a double audible alert notification when the glucose level information has been determined and displayed on
display screen 302. Additionally, in one embodiment, the time and date information may also be displayed on thedisplay screen 302 in connection with the generated glucose level information. - In accordance with another embodiment, the glucose meter device may be configured such that upon power on procedure, the light source (e.g., an LED) at the test strip port 306 (
FIG. 3 ) is configured to illuminate at substantially 50% of the full intensity to permit the introduction of thetest strip 102 into thetest strip port 306. Thereafter, when thetest strip 102 is fully inserted into thetest strip port 306 of the glucose meter device, the light source at thetest strip port 306, and alternatively, in addition to the backlight of thedisplay screen 302, is illuminated at the full intensity level to indicate blood sample collection operation. - When the collection of the blood sample is concluded, the intensity of the light source at the test strip port 306 (and alternatively, as well as the backlight of the display screen 302) are reduced substantially to the 50% level again, and when the test strip is removed from the
test strip port 306, the light source is configured to shut off completely. Indeed, as the light source (e.g., the LED) may be pulsed and still display substantially the same light output as one which is turned on in steady state, the battery life of the glucose meter device may be prolonged since the pulsed LED light source requires significantly less power (and thus draining the battery at a much slower rate) than when the LED light source is maintained at the on position. Indeed, in one embodiment, thecentral processing unit 206 of theglucose meter device 103 may be configured to control the switching on and off of the light source as well as the level of light intensity by, for example, adjusting the duty cycle and the period during which the light source is configured to be turned on. For example,FIG. 6 illustrates the output LED power level as a function of the power state in accordance with one embodiment of the present invention. As can be seen from the Figure, 50% duty cycle as shown on the X-axis corresponds to approximately 80% of the output power level for the LED light source. - In a preferred embodiment, a yellow/green LED is used for the test strip light, such as part number LT 19209-40 manufactured by Ledtech Electronics Corporation located in Hsin-Tien, Taiwan, or part number ZSG56W manufactured by SunLED Co. located in Kowloon, Hong Kong. These LEDs provide a light having a peak wavelength of about 575 nanometers, which has been found to provide optimal contrast between various colors of blood against various skin pigments in low light conditions. More specifically, using a yellow-green LED with peak wavelength of 570 nanometers in one embodiment provided optional contrast between the various colors of blood against the skin pigments in low light conditions.
- Also, preferably, the test light LED is pulsed faster than 60-100 hertz so that it appears to the human eye that it is continuously on without flickering, most preferably 3 or 7 khz. It has been discovered that a 10% duty cycle with the LEDs specified above provides the most desired balance between light intensity and battery power savings. A brighter light output than this can be disruptive in certain low light settings, such as a movie theater, and can inhibit inconspicuous blood glucose testing.
- In an alternate embodiment of the present invention, the glucose meter device may be configured such that the backlight on the
display screen 302 is turned on when thetest strip 102 is inserted into thetest strip port 306 of the meter device. Thereafter, the backlight is configured to turn off when the blood drop andtest strip symbols 414 are displayed in tandem to alert the user that the meter device is ready to apply the blood sample or the control solution. At the same time that the backlight is turned off, the light source at the test strip port 306 (e.g., the LED light source) is illuminated so that the user may light up thetest strip 102 and the sample acquisition site on theuser 101 if desired. Thereafter, when the meter device detects a sufficient level of blood sample on the test strip 102 (i.e., step 505 (FIG. 5 ) is successfully performed), the light source at thetest strip port 306 is disabled, and the backlight on thedisplay screen 302 is once again illuminated so that the user may view the corresponding glucose level generated from the collected blood sample. - In a slightly different embodiment, pressing the
light button 305 powers on either the display backlight or the test strip light, depending on what mode the meter is in. Pressing thelight button 305 in non-test modes powers on the display backlight. The display backlight goes out whenlight button 305 is pressed again, or when the meter is inactive for 5 seconds. Pressing the light button when the blood drop and test strip symbols appear on the display screen powers on the test strip light. The test strip light goes out when thelight button 305 is pressed again, or the meter receives the correct amount of blood for the test (i.e. the test strip is filled), or after 60 seconds of meter inactivity, or when the test strip is removed from the meter. Thus, in this embodiment, the test strip light cannot be activated unless there is a test strip inserted in the test strip port. If either the test strip light or the display backlight is used during the test mode, the backlight preferably powers on to show the test results after the measurement is complete. - Preferably, the glucose meter is powered by two coin cell batteries of a common size, such as CR2032. It is also preferable that one of the batteries is dedicated to powering the test strip light and display backlight, and the other is dedicated to powering the meter's processor and other functions. It may also be desirable to allow the meter to be placed in a “shelf mode” after final testing at the factory such that even with batteries inserted, nothing is shown on the display and the processor is in an energy saving sleep mode until one of the buttons is pressed or a test strip is inserted in the meter to resume normal operation.
- In the manner described above, in accordance with the various embodiments of the present invention, the
glucose meter device 103 is configured such that it is simple, intuitive and easy to use, permitting the user to perform the tests relatively discreetly, and is also easily used by third parties such as the user's physician, nurse, care giver or family member. Moreover, given the compact physical configuration, theglucose meter device 103 is substantially small, compact, sleek and readily portable by the user. - Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present invention and that structures and methods within the scope of these claims and their equivalents be covered thereby.
Claims (53)
1. A blood glucose meter, comprising:
a compact housing for a blood glucose meter;
a display unit disposed on the housing, the display unit configured to display information related to the blood glucose meter;
an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter; and
a power source provided within the housing for providing power to the blood glucose meter;
wherein the display unit includes a light source to illuminate the display unit; and further
wherein the light source has a wavelength within approximately 450 to 780 nanometers.
2. The meter of claim 1 , wherein the wavelength is approximately 570 nanometers.
3. The meter of claim 1 wherein the light source includes white light.
4. The meter of claim 1 wherein the display unit includes one of a liquid crystal display (LCD), a touch sensitive screen, or a plasma display unit.
5. The meter of claim 1 wherein the light source is configured to provide one or more of a backlight function or a flashlight function of the display unit.
6. The meter of claim 1 wherein the light source is configured to be pulsed at a frequency equal to or greater than approximately 0 Hertz.
7. The meter of claim 1 wherein the light source is configured to be pulsed at approximately 4 Khz.
8. The meter of claim 1 wherein the light source includes a light emitting diode (LED).
9. The meter of claim 8 wherein the LED is a yellow-green LED.
10. The meter of claim 1 including a lancing device operatively coupled to the compact housing.
11. A blood glucose meter, comprising:
a compact housing for a blood glucose meter;
a display unit disposed on the housing, the display unit configured to display information related to the blood glucose meter;
an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter; and
a power source provided within the housing for providing power to the blood glucose meter;
wherein the display unit includes a light source including a light emitting diode (LED) that is configured to be pulsed at a frequency equal to or greater than 0 Hertz.
12. The meter of claim 11 wherein the light emitting diode is configured to emit light in the white light broad spectrum.
13. The meter of claim 11 wherein the light emitting diode includes one or more of a yellow light emitting diode, a green light emitting diode, or a yellow/green light emitting diode.
14. The meter of claim 11 wherein the display unit includes one of a liquid crystal display (LCD), a touch sensitive screen, or a plasma display unit.
15. The meter of claim 11 wherein the display unit includes a light source to illuminate the display unit.
16. The meter of claim 11 wherein the light source is configured to provide a backlight function or a flashlight function of the display unit.
17. The meter of claim 11 including a lancing device operatively coupled to the compact housing.
18. A blood glucose meter, comprising:
a compact housing for a blood glucose meter;
a display unit disposed on the housing, the display unit configured to display information related to the blood glucose meter;
an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter; and
a power source provided within the housing for providing power to the blood glucose meter;
wherein the housing includes a port on said housing configured to receive a blood glucose test strip; and further
wherein the port includes a light source, the light source configured to substantially illuminate the port to assist in one or more of insertion of the blood glucose test strip into the port or removal of the blood glucose test strip.
19. The meter of claim 18 , wherein the light source of the port is configured to illuminate a sample acquisition site.
20. The meter of claim 19 wherein the blood sample acquisition site is located substantially on the surface of a patient's skin.
21. The meter of claim 20 wherein the surface of the patient's skin is positioned substantially at a predetermined angle relative to the direction of illumination from the port light source.
22. The meter of claim 21 wherein the predetermined angle is less than 90 degrees.
23. The meter of claim 19 wherein the sample acquisition site is illuminated only during a sample acquisition process.
24. The meter of claim 18 wherein the display unit is configured to illuminate upon detection of a glucose test strip insertion into the port.
25. The meter of claim 24 wherein the display unit is configured to remain illuminated until the test strip is removed from the port.
26. The meter of claim 18 wherein the input unit includes an on/off switch.
27. The meter of claim 18 including a lancing device integrated in the compact housing.
28. A blood glucose meter, comprising:
a compact housing for a blood glucose meter;
a display unit disposed on the housing, the display unit including a display light source to illuminate the display unit;
an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter; and
a power source provided within the housing for providing power to the blood glucose meter;
wherein the housing includes a port integrated on said housing configured to receive a blood glucose test strip, and further
wherein the display light source is configured to be pulsed at a frequency equal to or greater than 0 Hertz.
29. The meter of claim 28 herein the frequency is approximately 4 KHz.
30. The meter of claim 28 wherein the display unit includes one of a liquid crystal display (LCD), a touch sensitive screen, and a plasma display unit.
31. The meter of claim 28 wherein the display light source is configured to provide at least one of a backlight function or a flashlight function of the display unit.
32. The meter of claim 28 wherein the display light source includes a light emitting diode (LED).
33. The meter of claim 28 including a lancing device integrated in the compact housing.
34. A blood glucose meter, comprising:
a compact housing for a blood glucose meter;
a display unit disposed on the housing, the display unit including a display light source to illuminate the display unit;
an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter; and
a power source provided within the housing for providing power to the blood glucose meter;
wherein the housing includes a port integrated on said housing configured to receive a blood glucose test strip; and further
wherein the display light source has a wavelength within approximately 450 to 780 nanometers.
35. The meter of claim 34 , wherein the wavelength is approximately 570 nanometers.
36. The meter of claim 34 wherein the light source includes white light.
37. The meter of claim 34 wherein the display unit includes one of a liquid crystal display (LCD), a touch sensitive screen, or a plasma display unit.
38. The meter of claim 34 wherein the display light source is configured to provide one or more of a backlight function or a flashlight function of the display unit.
39. The meter of claim 34 wherein the display light source includes a light emitting diode (LED).
40. The meter of claim 34 including a lancing device integrated in the compact housing.
41. A blood glucose meter, comprising:
a compact housing for a blood glucose meter;
a display unit disposed on the housing, the display unit including a display light source to illuminate the display unit;
an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter; and
a power source provided within the housing for providing power to the blood glucose meter;
wherein the housing includes a port on said housing configured to receive a blood glucose test strip; and further
wherein the port includes a port light source, the port light source configured to substantially illuminate the port to assist in the insertion and/or removal of the blood glucose test strip.
42. The meter of claim 41 wherein the display unit includes one of a liquid crystal display (LCD), a touch sensitive screen, or a plasma display unit.
43. The meter of claim 41 wherein the display light source is configured to provide one or more of a backlight function or a flashlight function of the display unit.
44. The meter of claim 41 wherein the display light source includes a light emitting diode (LED).
45. The meter of claim 41 wherein the port light source is integrated with the display light source.
46. The meter of claim 41 wherein the display unit is configured to illuminate upon detection of a glucose test strip insertion into the port.
47. The meter of claim 46 wherein the display unit is configured to remain illuminated until the test strip is removed from the port.
48. The meter of claim 41 wherein the port light source is configured to illuminate a sample acquisition site.
49. The meter of claim 48 wherein the sample acquisition site is located substantially on the surface of a patient's skin.
50. The meter of claim 49 wherein the surface of the patient's skin is positioned substantially at a predetermined angle relative to the direction of illumination from the port light source.
51. The meter of claim 50 wherein the predetermined angle is less than 90 degrees.
52. The meter of claim 48 wherein the sample acquisition site is illuminated only during sample acquisition process.
53. The meter of claim 41 including a lancing device integrated to the compact housing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/040,586 US20080146900A1 (en) | 2003-06-12 | 2008-02-29 | Method and apparatus for providing power management in data communication systems |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47843603P | 2003-06-12 | 2003-06-12 | |
US10/861,626 US8071028B2 (en) | 2003-06-12 | 2004-06-04 | Method and apparatus for providing power management in data communication systems |
US12/040,586 US20080146900A1 (en) | 2003-06-12 | 2008-02-29 | Method and apparatus for providing power management in data communication systems |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/861,626 Continuation US8071028B2 (en) | 2003-06-12 | 2004-06-04 | Method and apparatus for providing power management in data communication systems |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080146900A1 true US20080146900A1 (en) | 2008-06-19 |
Family
ID=33567577
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/861,626 Active 2027-06-22 US8071028B2 (en) | 2003-06-12 | 2004-06-04 | Method and apparatus for providing power management in data communication systems |
US12/040,586 Abandoned US20080146900A1 (en) | 2003-06-12 | 2008-02-29 | Method and apparatus for providing power management in data communication systems |
US12/625,502 Expired - Fee Related US8273295B2 (en) | 2003-06-12 | 2009-11-24 | Apparatus for providing power management in data communication systems |
US12/644,431 Abandoned US20100099174A1 (en) | 2003-06-12 | 2009-12-22 | Method and Apparatus for Providing Power Management in Data Communication Systems |
US12/859,081 Active 2024-09-29 US8906307B2 (en) | 2003-06-12 | 2010-08-18 | Apparatus for providing power management in data communication systems |
US14/563,616 Expired - Lifetime US9109926B2 (en) | 2003-06-12 | 2014-12-08 | Method and apparatus for providing power management in data communication systems |
US14/808,202 Abandoned US20150330816A1 (en) | 2003-06-12 | 2015-07-24 | Method and Apparatus for Providing Power Management in Data Communication Systems |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/861,626 Active 2027-06-22 US8071028B2 (en) | 2003-06-12 | 2004-06-04 | Method and apparatus for providing power management in data communication systems |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/625,502 Expired - Fee Related US8273295B2 (en) | 2003-06-12 | 2009-11-24 | Apparatus for providing power management in data communication systems |
US12/644,431 Abandoned US20100099174A1 (en) | 2003-06-12 | 2009-12-22 | Method and Apparatus for Providing Power Management in Data Communication Systems |
US12/859,081 Active 2024-09-29 US8906307B2 (en) | 2003-06-12 | 2010-08-18 | Apparatus for providing power management in data communication systems |
US14/563,616 Expired - Lifetime US9109926B2 (en) | 2003-06-12 | 2014-12-08 | Method and apparatus for providing power management in data communication systems |
US14/808,202 Abandoned US20150330816A1 (en) | 2003-06-12 | 2015-07-24 | Method and Apparatus for Providing Power Management in Data Communication Systems |
Country Status (1)
Country | Link |
---|---|
US (7) | US8071028B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080129535A1 (en) * | 2004-12-13 | 2008-06-05 | Bayer Healthcare Llc | Method And Apparatus For Implementing Automatic Display Of Help Information With Detection Of Error Condition For Meter Connection |
CN102539774A (en) * | 2010-12-21 | 2012-07-04 | 中国科学院电子学研究所 | Handheld type multi-parameter on-site fast biochemical detector |
CN104137108A (en) * | 2011-12-29 | 2014-11-05 | 霍夫曼-拉罗奇有限公司 | Diabetes management application for mobile phone |
US8906307B2 (en) | 2003-06-12 | 2014-12-09 | Abbott Diabetes Care Inc. | Apparatus for providing power management in data communication systems |
JP2017037092A (en) * | 2009-09-29 | 2017-02-16 | ライフスキャン・スコットランド・リミテッドLifeScan Scotland, Ltd. | Analyte testing method and device for diabetes management |
US20170242683A1 (en) * | 2009-06-04 | 2017-08-24 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US11114188B2 (en) | 2009-10-06 | 2021-09-07 | Cercacor Laboratories, Inc. | System for monitoring a physiological parameter of a user |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL155682A0 (en) * | 2001-08-20 | 2003-11-23 | Inverness Medical Ltd | Wireless diabetes management devices and methods for using the same |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US7727181B2 (en) * | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
US7993108B2 (en) * | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
EP2383470A1 (en) * | 2002-10-09 | 2011-11-02 | Abbott Diabetes Care Inc. | Plunger pump actuated by a shape memory element |
US7679407B2 (en) * | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
CN101904739B (en) * | 2003-10-09 | 2013-01-16 | 日本电信电话株式会社 | Sphygmomanometer |
US8394328B2 (en) * | 2003-12-31 | 2013-03-12 | Nipro Diagnostics, Inc. | Test strip container with integrated meter having strip coding capability |
US9012232B2 (en) * | 2005-07-15 | 2015-04-21 | Nipro Diagnostics, Inc. | Diagnostic strip coding system and related methods of use |
US8394337B2 (en) * | 2003-12-31 | 2013-03-12 | Nipro Diagnostics, Inc. | Test strip container with integrated meter |
US8147426B2 (en) * | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
US8696880B2 (en) | 2004-02-06 | 2014-04-15 | Bayer Healthcare Llc | Oxidizable species as an internal reference for biosensors and method of use |
TWM268003U (en) * | 2004-07-23 | 2005-06-21 | Ebiologic Technology Co Ltd | A blood-carbohydrate measuring apparatus |
WO2006051466A1 (en) * | 2004-11-15 | 2006-05-18 | Koninklijke Philips Electronics N.V. | Ambulatory medical telemetry device having an audio indicator |
ITBO20050002A1 (en) * | 2005-01-04 | 2006-07-05 | Giacomo Vespasiani | METHOD AND SYSTEM FOR INTERACTIVE MANAGEMENT OF DATA CONCERNING AN INSULIN THERAPY IN SELF-CONTROL FOR A DIABETIC PATIENT |
US20060166629A1 (en) * | 2005-01-24 | 2006-07-27 | Therasense, Inc. | Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems |
US20060224141A1 (en) | 2005-03-21 | 2006-10-05 | Abbott Diabetes Care, Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7620437B2 (en) * | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US7955856B2 (en) * | 2005-07-15 | 2011-06-07 | Nipro Diagnostics, Inc. | Method of making a diagnostic test strip having a coding system |
US8999125B2 (en) | 2005-07-15 | 2015-04-07 | Nipro Diagnostics, Inc. | Embedded strip lot autocalibration |
ES2717135T3 (en) | 2005-07-20 | 2019-06-19 | Ascensia Diabetes Care Holdings Ag | Method to signal the user to add an additional sample to a test strip, method to measure the temperature of a sample and methods to determine the concentration of an analyte based on controlled amperometry |
WO2007040913A1 (en) | 2005-09-30 | 2007-04-12 | Bayer Healthcare Llc | Gated voltammetry |
US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
US8344966B2 (en) * | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US20070255178A1 (en) * | 2006-04-27 | 2007-11-01 | Lifescan Scotland, Ltd. | Method for lancing a target site in low ambient light conditions |
US20080020452A1 (en) * | 2006-07-18 | 2008-01-24 | Natasha Popovich | Diagnostic strip coding system with conductive layers |
JP5244116B2 (en) | 2006-10-24 | 2013-07-24 | バイエル・ヘルスケア・エルエルシー | Transient decay current measurement method |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
WO2008078128A1 (en) * | 2006-12-27 | 2008-07-03 | Chinasia Products Ltd | A portable blood analyzer for measuring the level of at least one compound contained in the blood of a patient |
EP2117421B1 (en) * | 2007-01-05 | 2014-08-13 | Bayer HealthCare LLC | Electrochemical test sensor with light guide |
US7734323B2 (en) | 2007-01-24 | 2010-06-08 | Smiths Medical Asd, Inc. | Correction factor testing using frequent blood glucose input |
US20080228056A1 (en) | 2007-03-13 | 2008-09-18 | Michael Blomquist | Basal rate testing using frequent blood glucose input |
US20200037875A1 (en) | 2007-05-18 | 2020-02-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
US8221345B2 (en) | 2007-05-30 | 2012-07-17 | Smiths Medical Asd, Inc. | Insulin pump based expert system |
WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
CN101463990B (en) * | 2007-12-19 | 2012-06-20 | 鸿富锦精密工业(深圳)有限公司 | Display with illumination function |
US20090177147A1 (en) | 2008-01-07 | 2009-07-09 | Michael Blomquist | Insulin pump with insulin therapy coaching |
US20090177142A1 (en) | 2008-01-09 | 2009-07-09 | Smiths Medical Md, Inc | Insulin pump with add-on modules |
USD612279S1 (en) | 2008-01-18 | 2010-03-23 | Lifescan Scotland Limited | User interface in an analyte meter |
USD611853S1 (en) | 2008-03-21 | 2010-03-16 | Lifescan Scotland Limited | Analyte test meter |
IL197532A0 (en) * | 2008-03-21 | 2009-12-24 | Lifescan Scotland Ltd | Analyte testing method and system |
USD615431S1 (en) | 2008-03-21 | 2010-05-11 | Lifescan Scotland Limited | Analyte test meter |
USD612275S1 (en) | 2008-03-21 | 2010-03-23 | Lifescan Scotland, Ltd. | Analyte test meter |
US20100121498A1 (en) * | 2008-05-08 | 2010-05-13 | Gable Kirkland R | System for collecting energy to identify with an object of interest |
US8132037B2 (en) | 2008-06-06 | 2012-03-06 | Roche Diagnostics International Ag | Apparatus and method for processing wirelessly communicated data and clock information within an electronic device |
US8117481B2 (en) * | 2008-06-06 | 2012-02-14 | Roche Diagnostics International Ag | Apparatus and method for processing wirelessly communicated information within an electronic device |
USD611151S1 (en) | 2008-06-10 | 2010-03-02 | Lifescan Scotland, Ltd. | Test meter |
US8465977B2 (en) | 2008-07-22 | 2013-06-18 | Roche Diagnostics Operations, Inc. | Method and apparatus for lighted test strip |
USD611489S1 (en) | 2008-07-25 | 2010-03-09 | Lifescan, Inc. | User interface display for a glucose meter |
USD611372S1 (en) | 2008-09-19 | 2010-03-09 | Lifescan Scotland Limited | Analyte test meter |
US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
US20100198196A1 (en) * | 2009-01-30 | 2010-08-05 | Abbott Diabetes Care, Inc. | Therapy Delivery Device Programming Tool |
US9065685B2 (en) * | 2009-02-13 | 2015-06-23 | Cisco Technology, Inc. | Network switch employing a proxy to facilitate power savings in a telephone network |
WO2010129375A1 (en) * | 2009-04-28 | 2010-11-11 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
EP4404212A2 (en) | 2009-07-23 | 2024-07-24 | Abbott Diabetes Care Inc. | Real time management of data relating to physiological control of glucose levels |
US8882701B2 (en) | 2009-12-04 | 2014-11-11 | Smiths Medical Asd, Inc. | Advanced step therapy delivery for an ambulatory infusion pump and system |
US8828330B2 (en) | 2010-01-28 | 2014-09-09 | Abbott Diabetes Care Inc. | Universal test strip port |
US9336353B2 (en) | 2010-06-25 | 2016-05-10 | Dexcom, Inc. | Systems and methods for communicating sensor data between communication devices of a glucose monitoring system |
WO2012037486A1 (en) | 2010-09-17 | 2012-03-22 | Agamatrix, Inc. | Method and apparatus for encoding test strips |
US8431408B2 (en) | 2010-10-15 | 2013-04-30 | Roche Diagnostics Operations, Inc. | Handheld diabetes managing device with light pipe for enhanced illumination |
US9241631B2 (en) | 2010-10-27 | 2016-01-26 | Dexcom, Inc. | Continuous analyte monitor data recording device operable in a blinded mode |
JP2012177554A (en) * | 2011-02-25 | 2012-09-13 | Gunze Ltd | Measurement display device |
EP2680754B1 (en) * | 2011-02-28 | 2019-04-24 | Abbott Diabetes Care, Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
WO2012122520A1 (en) | 2011-03-10 | 2012-09-13 | Abbott Diabetes Care Inc. | Multi-function analyte monitor device and methods of use |
EP2785245A4 (en) * | 2011-12-01 | 2015-08-19 | Modz Oy | Portable device for measuring blood samples |
US20150083590A1 (en) * | 2012-03-23 | 2015-03-26 | Modz Oy | Portable device assembly for measuring blood samples and a device cover |
KR102025060B1 (en) * | 2012-03-30 | 2019-09-25 | 라이프스캔 스코트랜드 리미티드 | Battery status detection and storage method and system in medical monitoring |
US9238100B2 (en) | 2012-06-07 | 2016-01-19 | Tandem Diabetes Care, Inc. | Device and method for training users of ambulatory medical devices |
US20140240359A1 (en) * | 2013-02-27 | 2014-08-28 | Lifescan Scotland Limited | Portable analyte meter with enhanced measurement display |
US8894262B2 (en) | 2013-03-11 | 2014-11-25 | Roche Diagnostic Operations, Inc. | Blood glucose test strip illumination device and method |
US10357606B2 (en) | 2013-03-13 | 2019-07-23 | Tandem Diabetes Care, Inc. | System and method for integration of insulin pumps and continuous glucose monitoring |
JP6479756B2 (en) * | 2013-03-14 | 2019-03-06 | トリビディア ヘルス,インコーポレーテッド | Measuring instrument with replaceable module |
US10016561B2 (en) | 2013-03-15 | 2018-07-10 | Tandem Diabetes Care, Inc. | Clinical variable determination |
KR20160006157A (en) * | 2013-05-10 | 2016-01-18 | 니프로 가부시키가이샤 | Measuring device |
US9383332B2 (en) * | 2013-09-24 | 2016-07-05 | Lifescan Scotland Limited | Analytical test strip with integrated battery |
US10481211B2 (en) | 2014-01-15 | 2019-11-19 | Lat Enterprises, Inc. | State-of-charge indicator |
US10036709B2 (en) | 2014-05-20 | 2018-07-31 | Roche Diabetes Care, Inc. | BG meter illuminated test strip |
US9669160B2 (en) | 2014-07-30 | 2017-06-06 | Tandem Diabetes Care, Inc. | Temporary suspension for closed-loop medicament therapy |
CN104569370A (en) * | 2015-01-16 | 2015-04-29 | 胡勋芳 | Glucometer |
EP3113054B1 (en) * | 2015-07-01 | 2019-09-04 | Roche Diabetes Care GmbH | A portable device and a method for collecting and processing continuous monitoring data indicative of an analyte in a bodily fluid, a medical system and a computer program product |
US10569016B2 (en) | 2015-12-29 | 2020-02-25 | Tandem Diabetes Care, Inc. | System and method for switching between closed loop and open loop control of an ambulatory infusion pump |
US10684271B2 (en) * | 2016-01-29 | 2020-06-16 | Insulet Corporation | Diagnostic medical device and methods of use thereof |
RU2725286C2 (en) | 2016-05-13 | 2020-06-30 | 4Д Молекьюлар Терапьютикс Инк. | Versions of adenoassociated virus capsids and methods of use thereof |
US20170348479A1 (en) | 2016-06-03 | 2017-12-07 | Bryan Choate | Adhesive system for drug delivery device |
PL3528691T3 (en) * | 2016-10-21 | 2023-12-11 | F. Hoffmann-La Roche Ag | Method for emphasizing analyte values during a therapeutic window |
USD872733S1 (en) | 2017-03-14 | 2020-01-14 | Insulet Corporation | Display screen with a graphical user interface |
USD872734S1 (en) | 2017-03-14 | 2020-01-14 | Insulet Corporation | Display screen with a graphical user interface |
BR112020005436B1 (en) | 2017-09-20 | 2022-08-02 | 4D Molecular Therapeutics Inc | ADENO-ASSOCIATED VIRUS VARIANT CAPSID PROTEIN, INFECTIOUS AAV VIRION (RAAV) VIRION, COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS AND USES OF RAAV VIRION OR PHARMACEUTICAL COMPOSITIONS |
PT3717636T (en) | 2017-11-27 | 2023-05-30 | 4D Molecular Therapeutics Inc | Adeno-associated virus variant capsids and use for inhibiting angiogenesis |
CN111954966A (en) | 2018-04-10 | 2020-11-17 | 坦德姆糖尿病护理股份有限公司 | System and method for inductively charging a medical device |
US11725741B2 (en) | 2018-07-17 | 2023-08-15 | Insulet Corporation | Low force valves for drug delivery pumps |
TWI699783B (en) * | 2018-11-08 | 2020-07-21 | 佛教慈濟醫療財團法人 | Intelligent medical treatment auxiliary system and method thereof |
JP2022520875A (en) | 2019-02-25 | 2022-04-01 | ノバルティス アーゲー | Compositions and Methods for Treating Bietti Crystallin Retinopathy |
CN113677801A (en) | 2019-02-25 | 2021-11-19 | 诺华股份有限公司 | Compositions and methods for treating BIETTI crystal dystrophy |
US11305333B2 (en) | 2020-03-31 | 2022-04-19 | Insulet Corporation | Methods for forming low stress component for medical devices |
Citations (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3930493A (en) * | 1974-01-23 | 1976-01-06 | Cordis Corporation | Intravascular liquid velocity sensing method using a polarographic electrode |
US4018547A (en) * | 1975-08-28 | 1977-04-19 | Rogen Neil E | Pumping by wire elongation |
US4439197A (en) * | 1981-03-23 | 1984-03-27 | Olympus Optical Co., Ltd. | Medical capsule device |
US4984581A (en) * | 1988-10-12 | 1991-01-15 | Flexmedics Corporation | Flexible guide having two-way shape memory alloy |
US5004532A (en) * | 1985-06-10 | 1991-04-02 | Orbisphere Corporation | Amperometric cell |
US5079920A (en) * | 1989-12-11 | 1992-01-14 | Whitehead Charles A | Hydraulic shape memory material stress to hydraulic pressure transducer |
US5081421A (en) * | 1990-05-01 | 1992-01-14 | At&T Bell Laboratories | In situ monitoring technique and apparatus for chemical/mechanical planarization endpoint detection |
US5278997A (en) * | 1990-12-17 | 1994-01-11 | Motorola, Inc. | Dynamically biased amplifier |
US5391250A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5404585A (en) * | 1991-09-19 | 1995-04-04 | Nokia Mobile Phones Ltd. | Power detector that employs a feedback circuit to enable class B operation of a detector transistor |
US5507288A (en) * | 1994-05-05 | 1996-04-16 | Boehringer Mannheim Gmbh | Analytical system for monitoring a substance to be analyzed in patient-blood |
US5592457A (en) * | 1980-07-16 | 1997-01-07 | Discovision Associates | System for recording digital information in a pulse-length modulation format |
US5604404A (en) * | 1993-01-21 | 1997-02-18 | Sony Corporation | Drive circuit for a cathode ray tube |
US5622482A (en) * | 1994-10-31 | 1997-04-22 | Daewood Electronics, Co., Ltd. | Pump using shape memory alloys |
US5622413A (en) * | 1994-08-17 | 1997-04-22 | Daewoo Electronics Co., Ltd. | Valve utilizing shape memory alloys and an anti-lock brake system with the valve |
US6027496A (en) * | 1997-03-25 | 2000-02-22 | Abbott Laboratories | Removal of stratum corneum by means of light |
US6027692A (en) * | 1995-04-07 | 2000-02-22 | Lxn Corporation | Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control |
US6027459A (en) * | 1996-12-06 | 2000-02-22 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6173160B1 (en) * | 1996-11-18 | 2001-01-09 | Nokia Mobile Phones Limited | Mobile station having drift-free pulsed power detection method and apparatus |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6185452B1 (en) * | 1997-02-26 | 2001-02-06 | Joseph H. Schulman | Battery-powered patient implantable device |
US6208894B1 (en) * | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
US6368274B1 (en) * | 1999-07-01 | 2002-04-09 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6375638B2 (en) * | 1999-02-12 | 2002-04-23 | Medtronic Minimed, Inc. | Incremental motion pump mechanisms powered by shape memory alloy wire or the like |
US6377894B1 (en) * | 1998-11-30 | 2002-04-23 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
US6506168B1 (en) * | 2000-05-26 | 2003-01-14 | Abbott Laboratories | Apparatus and method for obtaining blood for diagnostic tests |
US20030023317A1 (en) * | 2001-07-27 | 2003-01-30 | Dexcom, Inc. | Membrane for use with implantable devices |
US6514460B1 (en) * | 1999-07-28 | 2003-02-04 | Abbott Laboratories | Luminous glucose monitoring device |
US20030032874A1 (en) * | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US6522530B2 (en) * | 2000-08-04 | 2003-02-18 | Samsung Electronics Co., Ltd. | Computer system having a monitor movably coupled to a main body |
US6526298B1 (en) * | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US20030078560A1 (en) * | 2001-09-07 | 2003-04-24 | Miller Michael E. | Method and system for non-vascular sensor implantation |
US6679841B2 (en) * | 1998-02-17 | 2004-01-20 | Abbott Laboratories | Fluid collection and monitoring device |
US20040011671A1 (en) * | 1997-03-04 | 2004-01-22 | Dexcom, Inc. | Device and method for determining analyte levels |
US20040019321A1 (en) * | 2001-05-29 | 2004-01-29 | Sage Burton H. | Compensating drug delivery system |
US6687546B2 (en) * | 2000-01-21 | 2004-02-03 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method using a robust communication protocol |
US6700340B2 (en) * | 2002-03-19 | 2004-03-02 | Hamilton Beach/Proctor-Silex, Inc. | Control circuit for a coffee grinder |
US20040045879A1 (en) * | 1997-03-04 | 2004-03-11 | Dexcom, Inc. | Device and method for determining analyte levels |
US6840912B2 (en) * | 2001-12-07 | 2005-01-11 | Micronix, Inc | Consolidated body fluid testing device and method |
US20050009126A1 (en) * | 2003-06-12 | 2005-01-13 | Therasense, Inc. | Method and apparatus for providing power management in data communication systems |
US20050031689A1 (en) * | 2003-05-21 | 2005-02-10 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
US20050038680A1 (en) * | 2002-12-19 | 2005-02-17 | Mcmahon Kevin Lee | System and method for glucose monitoring |
US6859831B1 (en) * | 1999-10-06 | 2005-02-22 | Sensoria Corporation | Method and apparatus for internetworked wireless integrated network sensor (WINS) nodes |
US20050043598A1 (en) * | 2003-08-22 | 2005-02-24 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US20050053365A1 (en) * | 1997-10-06 | 2005-03-10 | Adams Dale R. | Portable DVD player |
US20050065464A1 (en) * | 2002-07-24 | 2005-03-24 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US20060001551A1 (en) * | 2004-06-30 | 2006-01-05 | Ulrich Kraft | Analyte monitoring system with wireless alarm |
US20060015020A1 (en) * | 2004-07-06 | 2006-01-19 | Dexcom, Inc. | Systems and methods for manufacture of an analyte-measuring device including a membrane system |
US6990372B2 (en) * | 2002-04-11 | 2006-01-24 | Alfred E. Mann Foundation For Scientific Research | Programmable signal analysis device for detecting neurological signals in an implantable device |
US20060016700A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060020190A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7003340B2 (en) * | 1998-03-04 | 2006-02-21 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US7020508B2 (en) * | 2002-08-22 | 2006-03-28 | Bodymedia, Inc. | Apparatus for detecting human physiological and contextual information |
US20070016381A1 (en) * | 2003-08-22 | 2007-01-18 | Apurv Kamath | Systems and methods for processing analyte sensor data |
US7186566B2 (en) * | 2003-07-28 | 2007-03-06 | Suyue Qian | Combining transmittance detection and chromatographic strip techniques for quantification of analyte in biological fluids |
US7192450B2 (en) * | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US20080021666A1 (en) * | 2003-08-01 | 2008-01-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US20080033254A1 (en) * | 2003-07-25 | 2008-02-07 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US20080045824A1 (en) * | 2003-10-28 | 2008-02-21 | Dexcom, Inc. | Silicone composition for biocompatible membrane |
US20080064941A1 (en) * | 2002-11-05 | 2008-03-13 | Funderburk Jeffery V | Sensor inserter methods of use |
US20090018424A1 (en) * | 2006-10-04 | 2009-01-15 | Dexcom, Inc. | Analyte sensor |
US20090030294A1 (en) * | 2004-05-03 | 2009-01-29 | Dexcom, Inc. | Implantable analyte sensor |
US20090036758A1 (en) * | 2003-12-09 | 2009-02-05 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US20090036763A1 (en) * | 2004-07-13 | 2009-02-05 | Dexcom, Inc. | Analyte sensor |
US20090062633A1 (en) * | 2004-05-03 | 2009-03-05 | Dexcorn, Inc. | Implantable analyte sensor |
US20090076356A1 (en) * | 2003-07-25 | 2009-03-19 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20090076360A1 (en) * | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
Family Cites Families (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4121282A (en) | 1976-01-21 | 1978-10-17 | Sony Corporation | Power supply circuit |
US4531235A (en) | 1983-06-20 | 1985-07-23 | Motorola, Inc. | Diversity signal strength indicator and site selection apparatus for using same |
EP0290683A3 (en) * | 1987-05-01 | 1988-12-14 | Diva Medical Systems B.V. | Diabetes management system and apparatus |
US5211626A (en) | 1987-05-01 | 1993-05-18 | Product Innovation Holdings Ltd. | Medical infusion apparatus |
JP2586495B2 (en) | 1987-07-02 | 1997-02-26 | 日本電気株式会社 | High frequency detection circuit |
US5108889A (en) * | 1988-10-12 | 1992-04-28 | Thorne, Smith, Astill Technologies, Inc. | Assay for determining analyte using mercury release followed by detection via interaction with aluminum |
US5366292A (en) | 1989-02-01 | 1994-11-22 | Leybold Ag | Sensor formed from a deformation heat recoverable material having a predetermined range of temperatures in which recovery occurs and used for measuring a physical characteristic of a system |
US5568400A (en) | 1989-09-01 | 1996-10-22 | Stark; Edward W. | Multiplicative signal correction method and apparatus |
US5050612A (en) * | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
US5051880A (en) | 1989-12-29 | 1991-09-24 | At&T Bell Laboratories | Mixed mode regulation controller for a resonant power converter |
WO1992001193A1 (en) * | 1990-07-11 | 1992-01-23 | Curtis Manufacturing Company, Inc. | Light apparatus for use with a compact computer video screen |
US5124661A (en) | 1990-07-23 | 1992-06-23 | I-Stat Corporation | Reusable test unit for simulating electrochemical sensor signals for quality assurance of portable blood analyzer instruments |
US5211371A (en) | 1991-07-22 | 1993-05-18 | Advanced Control Technologies, Inc. | Linearly actuated valve |
US5207666A (en) | 1991-08-30 | 1993-05-04 | Infusaid, Inc. | Passive shuttle metering device for implantable drug delivery system |
US20010011224A1 (en) | 1995-06-07 | 2001-08-02 | Stephen James Brown | Modular microprocessor-based health monitoring system |
US5956501A (en) * | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
US5899855A (en) * | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
CA2132277C (en) | 1993-10-22 | 2005-05-10 | Giorgio Cirelli | Injection device |
GB9325189D0 (en) | 1993-12-08 | 1994-02-09 | Unilever Plc | Methods and apparatus for electrochemical measurements |
US6425829B1 (en) | 1994-12-06 | 2002-07-30 | Nitinol Technologies, Inc. | Threaded load transferring attachment |
US5699243A (en) | 1995-02-02 | 1997-12-16 | Hubbell Incorporated | Motion sensing system with adaptive timing for controlling lighting fixtures |
US5575770A (en) | 1995-04-05 | 1996-11-19 | Therex Corporation | Implantable drug infusion system with safe bolus capability |
US5703928A (en) | 1995-09-26 | 1997-12-30 | Industrial Technology, Inc. | Probe for sampling differential electromagnetic fields |
US5661643A (en) | 1996-02-20 | 1997-08-26 | Eaton Corporation | Universal power module |
FI102580B1 (en) | 1996-06-17 | 1998-12-31 | Nokia Mobile Phones Ltd | A method for eliminating interference caused by a mobile station |
EP0878707A4 (en) | 1996-10-22 | 2000-06-28 | Riken Kk | Heating-type sensor |
US6063039A (en) | 1996-12-06 | 2000-05-16 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US5913833A (en) | 1997-02-07 | 1999-06-22 | Abbott Laboratories | Method and apparatus for obtaining biological fluids |
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
US6558321B1 (en) | 1997-03-04 | 2003-05-06 | Dexcom, Inc. | Systems and methods for remote monitoring and modulation of medical devices |
US7657297B2 (en) | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
GB9704737D0 (en) | 1997-03-07 | 1997-04-23 | Optel Instr Limited | Biological measurement system |
GB2328279B (en) | 1997-08-12 | 2001-10-10 | Abbott Lab | Optical glucose detector |
US6129823A (en) | 1997-09-05 | 2000-10-10 | Abbott Laboratories | Low volume electrochemical sensor |
US6764581B1 (en) | 1997-09-05 | 2004-07-20 | Abbott Laboratories | Electrode with thin working layer |
FR2768215B1 (en) | 1997-09-10 | 1999-11-19 | Agence Spatiale Europeenne | SYSTEM FOR LUBRICATING A MECHANISM, IN PARTICULAR A TURNING BEARING IN A SPACE MACHINE |
FI107080B (en) | 1997-10-27 | 2001-05-31 | Nokia Mobile Phones Ltd | measuring device |
US6144922A (en) | 1997-10-31 | 2000-11-07 | Mercury Diagnostics, Incorporated | Analyte concentration information collection and communication system |
US6155992A (en) | 1997-12-02 | 2000-12-05 | Abbott Laboratories | Method and apparatus for obtaining interstitial fluid for diagnostic tests |
US6073031A (en) | 1997-12-24 | 2000-06-06 | Nortel Networks Corporation | Desktop docking station for use with a wireless telephone handset |
WO1999037921A1 (en) | 1998-01-26 | 1999-07-29 | Massachusetts Institute Of Technology | Contractile actuated bellows pump |
US7647237B2 (en) | 1998-04-29 | 2010-01-12 | Minimed, Inc. | Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like |
GB2337122B (en) | 1998-05-08 | 2002-11-13 | Medisense Inc | Test strip |
US6569157B1 (en) | 1998-05-18 | 2003-05-27 | Abbott Laboratories | Removal of stratum corneum by means of light |
US7043287B1 (en) | 1998-05-18 | 2006-05-09 | Abbott Laboratories | Method for modulating light penetration depth in tissue and diagnostic applications using same |
US6132371A (en) | 1998-05-20 | 2000-10-17 | Hewlett-Packard Company | Leadless monitoring of physiological conditions |
US6077660A (en) | 1998-06-10 | 2000-06-20 | Abbott Laboratories | Diagnostic assay requiring a small sample of biological fluid |
US6312888B1 (en) | 1998-06-10 | 2001-11-06 | Abbott Laboratories | Diagnostic assay for a sample of biological fluid |
EP1090301B1 (en) | 1998-06-24 | 2002-07-31 | Transderm Technologies LLC | Non-invasive transdermal detection of analytes |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
US6248067B1 (en) | 1999-02-05 | 2001-06-19 | Minimed Inc. | Analyte sensor and holter-type monitor system and method of using the same |
EP2229879A1 (en) | 1998-10-08 | 2010-09-22 | Medtronic MiniMed, Inc. | Telemetered characteristic monitor system |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6242961B1 (en) | 1998-10-08 | 2001-06-05 | Altima Communication, Inc. | Methods and circuits for restoration of a drooped DC signal |
US6162202A (en) | 1998-10-26 | 2000-12-19 | Sicurelli; Robert | Flexible syringe needle |
US6081104A (en) | 1998-11-20 | 2000-06-27 | Applied Power Corporation | Method and apparatus for providing energy to a lighting system |
US6615061B1 (en) | 1998-11-23 | 2003-09-02 | Abbott Laboratories | Optical sensor having a selectable sampling distance for determination of analytes |
US6615074B2 (en) | 1998-12-22 | 2003-09-02 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Apparatus for energizing a remote station and related method |
US6067463A (en) | 1999-01-05 | 2000-05-23 | Abbott Laboratories | Method and apparatus for non-invasively measuring the amount of glucose in blood |
US6565738B1 (en) | 1999-01-28 | 2003-05-20 | Abbott Laboratories | Diagnostic test for the measurement of analyte in abiological fluid |
US6144303A (en) | 1999-02-01 | 2000-11-07 | Exi Wireless Systems, Inc. | Tag and system for patient safety monitoring |
US6835553B2 (en) | 1999-05-11 | 2004-12-28 | M-Biotech, Inc. | Photometric glucose measurement system using glucose-sensitive hydrogel |
US6752787B1 (en) | 1999-06-08 | 2004-06-22 | Medtronic Minimed, Inc., | Cost-sensitive application infusion device |
US6298255B1 (en) | 1999-06-09 | 2001-10-02 | Aspect Medical Systems, Inc. | Smart electrophysiological sensor system with automatic authentication and validation and an interface for a smart electrophysiological sensor system |
US6262708B1 (en) | 1999-06-16 | 2001-07-17 | Sun Microsystems, Inc. | Techniques for displaying complex characters |
GB2351153B (en) | 1999-06-18 | 2003-03-26 | Abbott Lab | Electrochemical sensor for analysis of liquid samples |
US7202734B1 (en) | 1999-07-06 | 2007-04-10 | Frederick Herbert Raab | Electronically tuned power amplifier |
US6160449A (en) | 1999-07-22 | 2000-12-12 | Motorola, Inc. | Power amplifying circuit with load adjust for control of adjacent and alternate channel power |
JP3323174B2 (en) | 1999-12-16 | 2002-09-09 | エヌイーシーネットワーク・センサ株式会社 | TDMA digital radio transmitter |
US20030060765A1 (en) * | 2000-02-16 | 2003-03-27 | Arthur Campbell | Infusion device menu structure and method of using the same |
US6350663B1 (en) | 2000-03-03 | 2002-02-26 | Agilent Technologies, Inc. | Method for reducing leakage currents of active area diodes and source/drain diffusions |
US6669669B2 (en) | 2001-10-12 | 2003-12-30 | Insulet Corporation | Laminated patient infusion device |
US20020118090A1 (en) | 2000-12-20 | 2002-08-29 | Byong-Ho Park | Shape memory alloy actuators activated by strain gradient variation during phase transformation |
US6471980B2 (en) | 2000-12-22 | 2002-10-29 | Avantec Vascular Corporation | Intravascular delivery of mycophenolic acid |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
WO2002054052A1 (en) | 2001-01-08 | 2002-07-11 | Leonard Fish | Diagnostic instruments and methods for detecting analytes |
US20040133092A1 (en) | 2001-03-27 | 2004-07-08 | Kain Aron Z. | Wireless system for measuring distension in flexible tubes |
AU2002309528A1 (en) | 2001-04-02 | 2002-10-15 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
FR2823618B1 (en) | 2001-04-13 | 2003-05-30 | Electricite De France | STAGE OF A HIGH FREQUENCY CURRENT POWER GENERATOR |
US6582393B2 (en) | 2001-05-29 | 2003-06-24 | Therafuse, Inc. | Compensating drug delivery system |
EP1395133B2 (en) | 2001-05-31 | 2013-07-24 | Abbott Laboratories | Polymer controlled induced viscosity fiber system and uses thereof |
US20030107487A1 (en) | 2001-12-10 | 2003-06-12 | Ronen Korman | Method and device for measuring physiological parameters at the wrist |
US6586971B1 (en) | 2001-12-18 | 2003-07-01 | Hewlett-Packard Development Company, L.P. | Adapting VLSI clocking to short term voltage transients |
US7153212B1 (en) * | 2002-02-01 | 2006-12-26 | Mad Catz, Inc. | Light attachment for portable electronic device |
US7379765B2 (en) | 2003-07-25 | 2008-05-27 | Dexcom, Inc. | Oxygen enhancing membrane systems for implantable devices |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US7024249B2 (en) | 2002-02-21 | 2006-04-04 | Alfred E. Mann Foundation For Scientific Research | Pulsed magnetic control system for interlocking functions of battery powered living tissue stimulators |
US6692457B2 (en) | 2002-03-01 | 2004-02-17 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US7175642B2 (en) * | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7052251B2 (en) | 2002-04-22 | 2006-05-30 | Medtronic Minimed, Inc. | Shape memory alloy wire driven positive displacement micropump with pulsatile output |
US6743635B2 (en) * | 2002-04-25 | 2004-06-01 | Home Diagnostics, Inc. | System and methods for blood glucose sensing |
US6946299B2 (en) * | 2002-04-25 | 2005-09-20 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
US7060192B2 (en) | 2002-05-09 | 2006-06-13 | Lifescan, Inc. | Methods of fabricating physiological sample collection devices |
US7226978B2 (en) | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
US6723072B2 (en) | 2002-06-06 | 2004-04-20 | Insulet Corporation | Plunger assembly for patient infusion device |
US7736309B2 (en) | 2002-09-27 | 2010-06-15 | Medtronic Minimed, Inc. | Implantable sensor method and system |
US7727181B2 (en) | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
US7399401B2 (en) | 2002-10-09 | 2008-07-15 | Abbott Diabetes Care, Inc. | Methods for use in assessing a flow condition of a fluid |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
JP2004135177A (en) * | 2002-10-11 | 2004-04-30 | Sharp Corp | Cellular phone |
CN1859943B (en) | 2002-10-11 | 2010-09-29 | 贝克顿·迪金森公司 | System for controlling concentration of glucose in a patient |
EP1578262A4 (en) | 2002-12-31 | 2007-12-05 | Therasense Inc | Continuous glucose monitoring system and methods of use |
US7154398B2 (en) | 2003-01-06 | 2006-12-26 | Chen Thomas C H | Wireless communication and global location enabled intelligent health monitoring system |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US7136704B2 (en) | 2003-04-16 | 2006-11-14 | Alfred E. Mann Foundation For Scientific Research | Blood oxygen monitoring system and a lead therefor |
US7266400B2 (en) | 2003-05-06 | 2007-09-04 | Orsense Ltd. | Glucose level control method and system |
US7366556B2 (en) | 2003-12-05 | 2008-04-29 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7424318B2 (en) | 2003-12-05 | 2008-09-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7467003B2 (en) | 2003-12-05 | 2008-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20050176136A1 (en) | 2003-11-19 | 2005-08-11 | Dexcom, Inc. | Afinity domain for analyte sensor |
US7460898B2 (en) | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
WO2005019795A2 (en) | 2003-07-25 | 2005-03-03 | Dexcom, Inc. | Electrochemical sensors including electrode systems with increased oxygen generation |
US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
EP1649260A4 (en) | 2003-07-25 | 2010-07-07 | Dexcom Inc | Electrode systems for electrochemical sensors |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7205409B2 (en) | 2003-09-04 | 2007-04-17 | Abbott Laboratories | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
EP2316953A3 (en) * | 2003-10-20 | 2011-10-05 | CropDesign N.V. | Identification of novel E2F target genes and use thereof |
US7123206B2 (en) | 2003-10-24 | 2006-10-17 | Medtronic Minimed, Inc. | System and method for multiple antennas having a single core |
WO2005051170A2 (en) | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US8774886B2 (en) | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
US8425416B2 (en) | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20080197024A1 (en) | 2003-12-05 | 2008-08-21 | Dexcom, Inc. | Analyte sensor |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US20080200788A1 (en) | 2006-10-04 | 2008-08-21 | Dexcorn, Inc. | Analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
EP2239566B1 (en) | 2003-12-05 | 2014-04-23 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
WO2005057173A2 (en) | 2003-12-08 | 2005-06-23 | Dexcom, Inc. | Systems and methods for improving electrochemical analyte sensors |
WO2005079257A2 (en) | 2004-02-12 | 2005-09-01 | Dexcom, Inc. | Biointerface with macro- and micro- architecture |
WO2005089103A2 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US20070135697A1 (en) | 2004-04-19 | 2007-06-14 | Therasense, Inc. | Method and apparatus for providing sensor guard for data monitoring and detection systems |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20080242961A1 (en) | 2004-07-13 | 2008-10-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7857760B2 (en) | 2004-07-13 | 2010-12-28 | Dexcom, Inc. | Analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US20060166629A1 (en) | 2005-01-24 | 2006-07-27 | Therasense, Inc. | Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8298142B2 (en) | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US8447376B2 (en) | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
US20080306434A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9839395B2 (en) | 2007-12-17 | 2017-12-12 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20090299155A1 (en) | 2008-01-30 | 2009-12-03 | Dexcom, Inc. | Continuous cardiac marker sensor system |
EP2244761A2 (en) | 2008-02-20 | 2010-11-03 | Dexcom, Inc. | Continous medicament sensor system for in vivo use |
US8591455B2 (en) | 2008-02-21 | 2013-11-26 | Dexcom, Inc. | Systems and methods for customizing delivery of sensor data |
US20090242399A1 (en) | 2008-03-25 | 2009-10-01 | Dexcom, Inc. | Analyte sensor |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
US20090247856A1 (en) | 2008-03-28 | 2009-10-01 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
-
2004
- 2004-06-04 US US10/861,626 patent/US8071028B2/en active Active
-
2008
- 2008-02-29 US US12/040,586 patent/US20080146900A1/en not_active Abandoned
-
2009
- 2009-11-24 US US12/625,502 patent/US8273295B2/en not_active Expired - Fee Related
- 2009-12-22 US US12/644,431 patent/US20100099174A1/en not_active Abandoned
-
2010
- 2010-08-18 US US12/859,081 patent/US8906307B2/en active Active
-
2014
- 2014-12-08 US US14/563,616 patent/US9109926B2/en not_active Expired - Lifetime
-
2015
- 2015-07-24 US US14/808,202 patent/US20150330816A1/en not_active Abandoned
Patent Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3930493A (en) * | 1974-01-23 | 1976-01-06 | Cordis Corporation | Intravascular liquid velocity sensing method using a polarographic electrode |
US4018547A (en) * | 1975-08-28 | 1977-04-19 | Rogen Neil E | Pumping by wire elongation |
US5592457A (en) * | 1980-07-16 | 1997-01-07 | Discovision Associates | System for recording digital information in a pulse-length modulation format |
US4439197A (en) * | 1981-03-23 | 1984-03-27 | Olympus Optical Co., Ltd. | Medical capsule device |
US5004532A (en) * | 1985-06-10 | 1991-04-02 | Orbisphere Corporation | Amperometric cell |
US4984581A (en) * | 1988-10-12 | 1991-01-15 | Flexmedics Corporation | Flexible guide having two-way shape memory alloy |
US5079920A (en) * | 1989-12-11 | 1992-01-14 | Whitehead Charles A | Hydraulic shape memory material stress to hydraulic pressure transducer |
US5081421A (en) * | 1990-05-01 | 1992-01-14 | At&T Bell Laboratories | In situ monitoring technique and apparatus for chemical/mechanical planarization endpoint detection |
US5278997A (en) * | 1990-12-17 | 1994-01-11 | Motorola, Inc. | Dynamically biased amplifier |
US5404585A (en) * | 1991-09-19 | 1995-04-04 | Nokia Mobile Phones Ltd. | Power detector that employs a feedback circuit to enable class B operation of a detector transistor |
US5604404A (en) * | 1993-01-21 | 1997-02-18 | Sony Corporation | Drive circuit for a cathode ray tube |
US5391250A (en) * | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5507288A (en) * | 1994-05-05 | 1996-04-16 | Boehringer Mannheim Gmbh | Analytical system for monitoring a substance to be analyzed in patient-blood |
US5507288B1 (en) * | 1994-05-05 | 1997-07-08 | Boehringer Mannheim Gmbh | Analytical system for monitoring a substance to be analyzed in patient-blood |
US5622413A (en) * | 1994-08-17 | 1997-04-22 | Daewoo Electronics Co., Ltd. | Valve utilizing shape memory alloys and an anti-lock brake system with the valve |
US5622482A (en) * | 1994-10-31 | 1997-04-22 | Daewood Electronics, Co., Ltd. | Pump using shape memory alloys |
US6027692A (en) * | 1995-04-07 | 2000-02-22 | Lxn Corporation | Apparatus for combined assay for current glucose level and intermediate or long-term glycemic control |
US6173160B1 (en) * | 1996-11-18 | 2001-01-09 | Nokia Mobile Phones Limited | Mobile station having drift-free pulsed power detection method and apparatus |
US6027459A (en) * | 1996-12-06 | 2000-02-22 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6206841B1 (en) * | 1996-12-06 | 2001-03-27 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6837858B2 (en) * | 1996-12-06 | 2005-01-04 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
US6185452B1 (en) * | 1997-02-26 | 2001-02-06 | Joseph H. Schulman | Battery-powered patient implantable device |
US6208894B1 (en) * | 1997-02-26 | 2001-03-27 | Alfred E. Mann Foundation For Scientific Research And Advanced Bionics | System of implantable devices for monitoring and/or affecting body parameters |
US20040011671A1 (en) * | 1997-03-04 | 2004-01-22 | Dexcom, Inc. | Device and method for determining analyte levels |
US20040045879A1 (en) * | 1997-03-04 | 2004-03-11 | Dexcom, Inc. | Device and method for determining analyte levels |
US6862465B2 (en) * | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
US6027496A (en) * | 1997-03-25 | 2000-02-22 | Abbott Laboratories | Removal of stratum corneum by means of light |
US20050053365A1 (en) * | 1997-10-06 | 2005-03-10 | Adams Dale R. | Portable DVD player |
US6679841B2 (en) * | 1998-02-17 | 2004-01-20 | Abbott Laboratories | Fluid collection and monitoring device |
US7003340B2 (en) * | 1998-03-04 | 2006-02-21 | Abbott Diabetes Care Inc. | Electrochemical analyte sensor |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6526298B1 (en) * | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US6377894B1 (en) * | 1998-11-30 | 2002-04-23 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
US6375638B2 (en) * | 1999-02-12 | 2002-04-23 | Medtronic Minimed, Inc. | Incremental motion pump mechanisms powered by shape memory alloy wire or the like |
US6368274B1 (en) * | 1999-07-01 | 2002-04-09 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6514460B1 (en) * | 1999-07-28 | 2003-02-04 | Abbott Laboratories | Luminous glucose monitoring device |
US6859831B1 (en) * | 1999-10-06 | 2005-02-22 | Sensoria Corporation | Method and apparatus for internetworked wireless integrated network sensor (WINS) nodes |
US6873268B2 (en) * | 2000-01-21 | 2005-03-29 | Medtronic Minimed, Inc. | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
US6687546B2 (en) * | 2000-01-21 | 2004-02-03 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method using a robust communication protocol |
US6694191B2 (en) * | 2000-01-21 | 2004-02-17 | Medtronic Minimed, Inc. | Ambulatory medical apparatus and method having telemetry modifiable control software |
US6506168B1 (en) * | 2000-05-26 | 2003-01-14 | Abbott Laboratories | Apparatus and method for obtaining blood for diagnostic tests |
US6522530B2 (en) * | 2000-08-04 | 2003-02-18 | Samsung Electronics Co., Ltd. | Computer system having a monitor movably coupled to a main body |
US20040019321A1 (en) * | 2001-05-29 | 2004-01-29 | Sage Burton H. | Compensating drug delivery system |
US20030023317A1 (en) * | 2001-07-27 | 2003-01-30 | Dexcom, Inc. | Membrane for use with implantable devices |
US6702857B2 (en) * | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US20090045055A1 (en) * | 2001-07-27 | 2009-02-19 | Dexcom, Inc. | Sensor head for use with implantable devices |
US20030032874A1 (en) * | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US20030078560A1 (en) * | 2001-09-07 | 2003-04-24 | Miller Michael E. | Method and system for non-vascular sensor implantation |
US6840912B2 (en) * | 2001-12-07 | 2005-01-11 | Micronix, Inc | Consolidated body fluid testing device and method |
US6700340B2 (en) * | 2002-03-19 | 2004-03-02 | Hamilton Beach/Proctor-Silex, Inc. | Control circuit for a coffee grinder |
US6990372B2 (en) * | 2002-04-11 | 2006-01-24 | Alfred E. Mann Foundation For Scientific Research | Programmable signal analysis device for detecting neurological signals in an implantable device |
US20050065464A1 (en) * | 2002-07-24 | 2005-03-24 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US7020508B2 (en) * | 2002-08-22 | 2006-03-28 | Bodymedia, Inc. | Apparatus for detecting human physiological and contextual information |
US20080064941A1 (en) * | 2002-11-05 | 2008-03-13 | Funderburk Jeffery V | Sensor inserter methods of use |
US20050038680A1 (en) * | 2002-12-19 | 2005-02-17 | Mcmahon Kevin Lee | System and method for glucose monitoring |
US7192450B2 (en) * | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US20050031689A1 (en) * | 2003-05-21 | 2005-02-10 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
US20050009126A1 (en) * | 2003-06-12 | 2005-01-13 | Therasense, Inc. | Method and apparatus for providing power management in data communication systems |
US20090076356A1 (en) * | 2003-07-25 | 2009-03-19 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20080033254A1 (en) * | 2003-07-25 | 2008-02-07 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US7186566B2 (en) * | 2003-07-28 | 2007-03-06 | Suyue Qian | Combining transmittance detection and chromatographic strip techniques for quantification of analyte in biological fluids |
US20080021666A1 (en) * | 2003-08-01 | 2008-01-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US20090012379A1 (en) * | 2003-08-01 | 2009-01-08 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US20070016381A1 (en) * | 2003-08-22 | 2007-01-18 | Apurv Kamath | Systems and methods for processing analyte sensor data |
US20050043598A1 (en) * | 2003-08-22 | 2005-02-24 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US20080045824A1 (en) * | 2003-10-28 | 2008-02-21 | Dexcom, Inc. | Silicone composition for biocompatible membrane |
US20090043541A1 (en) * | 2003-12-09 | 2009-02-12 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US20090036758A1 (en) * | 2003-12-09 | 2009-02-05 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US20090043525A1 (en) * | 2003-12-09 | 2009-02-12 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US20090043182A1 (en) * | 2003-12-09 | 2009-02-12 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US20090043542A1 (en) * | 2003-12-09 | 2009-02-12 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US20090043181A1 (en) * | 2003-12-09 | 2009-02-12 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US20090062635A1 (en) * | 2003-12-09 | 2009-03-05 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US20090030294A1 (en) * | 2004-05-03 | 2009-01-29 | Dexcom, Inc. | Implantable analyte sensor |
US20090062633A1 (en) * | 2004-05-03 | 2009-03-05 | Dexcorn, Inc. | Implantable analyte sensor |
US20060001551A1 (en) * | 2004-06-30 | 2006-01-05 | Ulrich Kraft | Analyte monitoring system with wireless alarm |
US20060015020A1 (en) * | 2004-07-06 | 2006-01-19 | Dexcom, Inc. | Systems and methods for manufacture of an analyte-measuring device including a membrane system |
US20060036142A1 (en) * | 2004-07-13 | 2006-02-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7494465B2 (en) * | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060036145A1 (en) * | 2004-07-13 | 2006-02-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060036140A1 (en) * | 2004-07-13 | 2006-02-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20080071156A1 (en) * | 2004-07-13 | 2008-03-20 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060036141A1 (en) * | 2004-07-13 | 2006-02-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20090076361A1 (en) * | 2004-07-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060036144A1 (en) * | 2004-07-13 | 2006-02-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060036139A1 (en) * | 2004-07-13 | 2006-02-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20090036763A1 (en) * | 2004-07-13 | 2009-02-05 | Dexcom, Inc. | Analyte sensor |
US20060020189A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060020191A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060019327A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060020186A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060020187A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060020192A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060036143A1 (en) * | 2004-07-13 | 2006-02-16 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7497827B2 (en) * | 2004-07-13 | 2009-03-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060020188A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060020190A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060016700A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20090018424A1 (en) * | 2006-10-04 | 2009-01-15 | Dexcom, Inc. | Analyte sensor |
US20090076360A1 (en) * | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8906307B2 (en) | 2003-06-12 | 2014-12-09 | Abbott Diabetes Care Inc. | Apparatus for providing power management in data communication systems |
US9109926B2 (en) | 2003-06-12 | 2015-08-18 | Abbott Diabetes Care Inc. | Method and apparatus for providing power management in data communication systems |
US20080129535A1 (en) * | 2004-12-13 | 2008-06-05 | Bayer Healthcare Llc | Method And Apparatus For Implementing Automatic Display Of Help Information With Detection Of Error Condition For Meter Connection |
US20170242683A1 (en) * | 2009-06-04 | 2017-08-24 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US11152112B2 (en) * | 2009-06-04 | 2021-10-19 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US11309078B2 (en) | 2009-06-04 | 2022-04-19 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
US11854693B2 (en) | 2009-06-04 | 2023-12-26 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
JP2017037092A (en) * | 2009-09-29 | 2017-02-16 | ライフスキャン・スコットランド・リミテッドLifeScan Scotland, Ltd. | Analyte testing method and device for diabetes management |
US11114188B2 (en) | 2009-10-06 | 2021-09-07 | Cercacor Laboratories, Inc. | System for monitoring a physiological parameter of a user |
US11342072B2 (en) | 2009-10-06 | 2022-05-24 | Cercacor Laboratories, Inc. | Optical sensing systems and methods for detecting a physiological condition of a patient |
CN102539774A (en) * | 2010-12-21 | 2012-07-04 | 中国科学院电子学研究所 | Handheld type multi-parameter on-site fast biochemical detector |
CN104137108A (en) * | 2011-12-29 | 2014-11-05 | 霍夫曼-拉罗奇有限公司 | Diabetes management application for mobile phone |
Also Published As
Publication number | Publication date |
---|---|
US20150090031A1 (en) | 2015-04-02 |
US20100312085A1 (en) | 2010-12-09 |
US9109926B2 (en) | 2015-08-18 |
US20150330816A1 (en) | 2015-11-19 |
US8273295B2 (en) | 2012-09-25 |
US8071028B2 (en) | 2011-12-06 |
US8906307B2 (en) | 2014-12-09 |
US20050009126A1 (en) | 2005-01-13 |
US20100137698A1 (en) | 2010-06-03 |
US20100099174A1 (en) | 2010-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9109926B2 (en) | Method and apparatus for providing power management in data communication systems | |
US20210177361A1 (en) | Analyte monitoring system with audible feedback | |
ES2589929T3 (en) | Measuring device that has an alarm that indicates when to test after a meal | |
US20170000426A1 (en) | Displays for a Medical Device | |
EP2377465B1 (en) | Biological information measurement device, illumination method in a biological information measurement device, and biological information measurement method | |
US20100152554A1 (en) | Monitoring device | |
US20100331650A1 (en) | Episodic blood glucose monitoring system with an interactive graphical user interface and methods thereof | |
US20040254429A1 (en) | Data storage device for integrating data of several medical measuring instruments | |
JP2006522346A (en) | Method and system for transferring analyte test data | |
US7211047B2 (en) | Blood pressure monitor | |
WO2010095675A1 (en) | System for measuring biological information, method for measuring biological information, blood sugar meter, body composition meter and sphygmomanometer | |
CN101194838A (en) | Non-invasive blood sugar detecting instrument | |
EP1121897A2 (en) | Bio-characteristic value measuring apparatus with simplified setting and display recognition | |
CN105138844B (en) | A kind of information processing method, device and smartwatch | |
WO2006132953A2 (en) | Solar-powered integrated-diagnostic instrument | |
JPWO2013038826A1 (en) | Notification system | |
US20070106125A1 (en) | Biosensor capable of setting standard measuring values | |
CN211434407U (en) | Peritoneal dialysis assistant | |
KR100856010B1 (en) | Apparatus for measuring time-course glucose variation and system using the apparatus | |
WO2008056199A1 (en) | An infrared thermometer with color change lighting display for measuring the temperature of a patient | |
EP2113110A1 (en) | Monitoring device | |
TW201344636A (en) | Group physiological message detection device and wireless control and healthcare method of cardiovascular disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THERASENSE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ANDREWS, TAE WAN;BUBRICK, STEPHEN C.;ESTOESTA, SHEILAH S.;AND OTHERS;SIGNING DATES FROM 20041215 TO 20050209;REEL/FRAME:031437/0391 Owner name: ABBOTT DIABETES CARE INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:THERASENSE, INC.;REEL/FRAME:031439/0736 Effective date: 20050725 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |